Prof. H.W.M. van Laarhoven PhD publications

foto

Publications Prof. PhD H.W.M. van Laarhoven

Position
Full Professor
Main activities
Patient care, Research
Specialisation
Medical Oncologist
Focus of research

1. Translational research in oncology

2. Clinical oncological studies and real world data analysis

2. Psychosocial and supportive care

2021

  • Dijksterhuis Willemieke P M, Latenstein Anouk E J, van Kleef Jessy Joy, Verhoeven Rob H A, de Vries Jeanne H M, Slingerland Marije, Steenhagen Elles, Heisterkamp Joos, Timmermans Liesbeth M, de van der Schueren Marian A E, van Oijen Martijn G H, Beijer Sandra, van Laarhoven Hanneke W M Cachexia and Dietetic Interventions in Patients With Esophagogastric Cancer: A Multicenter Cohort Study Journal of the National Comprehensive Cancer Network 2021:1-9 [PubMed]
  • Luijten Josianne C. H. B. M., Vissers Pauline A. J., Lingsma Hester, van Leeuwen Nikki, Rozema Tom, Siersema Peter D., Rosman Camiel, van Laarhoven Hanneke W. M., Lemmens Valery E. P., Nieuwenhuijzen Grard A. P., Verhoeven Rob H. A. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer Cancer epidemiology 2021;71 [PubMed]
  • Meijer L., Verhoeven R. H. A., de Hingh I. H. J. T., van de Wouw A. J., van Laarhoven H. W. M., Lemmens V. E. P. P., Loef C. Extensive diagnostic work-up for patients with carcinoma of unknown primary Clinical & experimental metastasis 2021 [PubMed]
  • Besseling Joost, Reitsma Jan, van Erkelens Judith A., Schepens Maike H. J., Siroen Michiel P. C., Ziedses des Plantes Cathelijne M. P., van Berge Henegouwen Mark I., Beerepoot Laurens V., Voorthuizen Theo Van, Zuylen Lia Van, Verhoeven Rob H. A., van Laarhoven Hanneke Use of palliative chemotherapy and icu admissions in gastric and esophageal cancer patients in the last phase of life: A nationwide observational study Cancers 2021;13 (1):1-10 [PubMed]
  • Bos-van den Hoek Danique W., Thodé Maureen, Jongerden Irene P., van Laarhoven Hanneke W. M., Smets Ellen M. A., Tange Dorien, Henselmans Inge, Pasman H. Roeline 医院护士在延长生命治疗共同决策中的作用:定性访谈研究 Journal of advanced nursing 2021;77 (1):296-307 [PubMed]

2020

  • de Steur W. O., van Amelsfoort R. M., Hartgrink H. H., Putter H., Meershoek-Klein Kranenbarg E., van Grieken N. C. T., van Sandick J. W., Claassen Y. H. M., Braak J. P. B. M., Jansen E. P. M., Sikorska K., van Tinteren H., Walraven I., Lind P., Nordsmark M., van Berge Henegouwen M. I., van Laarhoven H. W. M., Cats A., Verheij M., van de Velde C. J. H. Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial Annals of oncology 2020 [PubMed]
  • de Vos-Geelen Judith, Hoebers Frank J. P., Geurts Sandra M. E., Hoeben Ann, de Greef Bianca T. A., Voncken Francine E. M., Bogers J. (Hans) A., Braam P. tra M., Muijs C. (Kristel) T., de Jong Martin A., Kasperts Nicolien, Rozema Tom, Jeene Paul M., Blom Gerrit J., van Dieren Jolanda M., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Grabsch Heike I., Lemmens Valery E. P. P., Tjan-Heijnen Vivianne C. G., Nieuwenhuijzen Grard A. P. A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer Acta oncologica (Stockholm, Sweden) 2020;59 (8):895-903 [PubMed]
  • Latenstein Anouk E. J., Dijksterhuis Willemieke P. M., Mackay Tara M., Beijer Sandra, van Eijck Casper H. J., de Hingh Ignace H. J. T., Molenaar I. Quintus, van Oijen Martijn G. H., van Santvoort Hjalmar C., de van der Schueren Marian A. E., de Vos-Geelen Judith, de Vries Jeanne H. M., Wilmink Johanna W., Besselink Marc G., van Laarhoven Hanneke W. M. Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study Cancer medicine 2020;9 (24):9385-9395 [PubMed]
  • van den Berg M. M. G. A., Kok D. E., Visser M., de Vries J. H. M., de Kruif J. Th. C. M., de Vries Y., Posthuma L., Sommeijer D. W., Timmer-Bonte A., Los M., van Laarhoven H. W. M., Kampman E., Winkels Renate M., Sommeijer Dirkje W. Changes in body composition during and after adjuvant or neo-adjuvant chemotherapy in women with breast cancer stage I–IIIB compared with changes over a similar timeframe in women without cancer Supportive care in cancer 2020;28 (4):1685-1693 [PubMed]
  • Strijker Marin, Soer Eline C., de Pastena Matteo, Creemers Aafke, Balduzzi Alberto, Beagan Jamie J., Busch Olivier R., van Delden Otto M., Halfwerk Hans, van Hooft Jeanin E., van Lienden Krijn P., Marchegiani Giovanni, Meijer Sybren L., van Noesel Carel J., Reinten Roy J., Roos Eva, Schokker Sandor, Verheij Joanne, van de Vijver Marc J., Waasdorp Cynthia, Wilmink Johanna W., Ylstra Bauke, Besselink Marc G., Bijlsma Maarten F., Dijk Frederike, van Laarhoven Hanneke W. Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma International journal of cancer. Journal international du cancer 2020;146 (5):1445-1456 [PubMed]
  • Rensink M. J., van Laarhoven H. W. M., Holleman F. Cocoon vaccination for influenza in patients with a solid tumor: a retrospective study Supportive care in cancer 2020 [PubMed]
  • le Large Tessa Y. S., Meijer Laura L., Paleckyte Rosita, Boyd Lenka N. C., Kok Bart, Wurdinger Thomas, Schelfhorst Tim, Piersma Sander R., Pham Thang V., van Grieken Nicole C. T., Zonderhuis Barbara M., Daams Freek, van Laarhoven Hanneke W. M., Bijlsma Maarten F., Jimenez Connie R., Giovannetti Elisa, Kazemier Geert Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach oncologist 2020;25 (4):e634-e643 [PubMed]
  • van de Water L. F., van Kleef J. J., Dijksterhuis W. P. M., Henselmans I., van den Boorn H. G., Vaarzon Morel N. M., Schut K. F., Daams J. G., Smets E. M. A., van Laarhoven H. W. M. Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods Quality of life research 2020;29 (7):1747-1766 [PubMed]
  • Roos Eva, Strijker Marin, Franken Lotte C., Busch Olivier R., van Hooft Jeanin E., Klümpen Heinz-Josef, van Laarhoven Hanneke W., Wilmink Johanna W., Verheij Joanne, van Gulik Thomas M., Besselink Marc G. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center HPB: The official journal of the International Hepato Pancreato Biliary Association 2020;22 (3):405-414 [PubMed]
  • Hagens E. R. C., Feenstra M. L., Eshuis W. J., Hulshof M. C. C. M., van Laarhoven H. W. M., van Berge Henegouwen M. I., Gisbertz S. S. Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer British journal of surgery 2020;107 (8):1053-1061 [PubMed]
  • Latenstein Anouk E. J., van Roessel Stijn, van der Geest Lydia G. M., Bonsing Bert A., Dejong Cornelis H. C., Groot Koerkamp Bas, de Hingh Ignace H. J. T., Homs Marjolein Y. V., Klaase Joost M., Lemmens Valery, Molenaar I. Quintus, Steyerberg Ewout W., Stommel Martijn W. J., Busch Olivier R., van Eijck Casper H. J., van Laarhoven Hanneke W. M., Wilmink Johanna W., Besselink Marc G. Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model Annals of surgical oncology 2020;27 (7):2516-2524 [PubMed]
  • Schokker Sandor, Fusetti Fabrizia, Bonardi Francesco, Molenaar Remco J., Mathôt Ron A. A., van Laarhoven Hanneke W. M. Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab mAbs 2020;12 (1) [PubMed]
  • Hagens Eliza R. C., Künzli Hannah T., van Rijswijk Anne-Sophie, Meijer Sybren L., Mijnals R. Clinton D., Weusten Bas L. A. M., Geijsen E. Debby, van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I., Gisbertz Suzanne S. Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study Surgical endoscopy 2020;34 (10):4347-4357 [PubMed]
  • de Joode Karlijn, Dumoulin Daphne W., Tol Jolien, Westgeest Hans M., Beerepoot Laurens V., van den Berkmortel Franchette W. P. J., Mutsaers Pim G. N. J., van Diemen Nico G. J., Visser Otto J., Oomen-de Hoop Esther, Bloemendal Haiko J., van Laarhoven Hanneke W. M., Hendriks Lizza E. L., Haanen John B. A. G., de Vries Elisabeth G. E., Dingemans Anne-Marie C., van der Veldt Astrid A. M., van Loenhout C. J., van der Leest C. H., Becker-Commissaris A., Borgers J. S. W., Terhegggen F., van den Borne B. E. E. M., van Warmerdam L. J. C., van Leeuwen L., van der Meer F. S., Tiemessen M. A., van Diepen D. M., Klaver Y., Hamberg A. P., Libourel E. J., Strobbe L., Cloos M., Geraedts E. J., Drooger J. C., Heller R., de Groot J. W. B., Stigt J. A., Nuij V. J. A. A., Pitz C. C. M., Slingerland M., Borm F. J., Haberkorn B. C. M., Westeinde S. C. van 't, Aarts M. J. B., van Putten J. W. G., Youssef M., Cirkel G. A., Herder G. J. M., van Rooijen C. R., Citgez E., Barlo N. P., Scholtes B. M. J., Koornstra R. H. T., Claessens N. J. M., Faber L. M., Rikers C. H., van de Wetering R. A. W., Veurink G. L., Bouter B. W., Houtenbos I., Bard M. P. L., Herbschleb K. H., Kastelijn E. A., Brocken P., Douma G., Jalving M., Hiltermann T. J. N., Schuurbiers-Siebers O. C. J., Suijkerbuijk K. P. M., van Lindert A. S. R., van de Wouw A. J., van den Boogaart V. E. M., Bakker S. D., Looysen E., Peerdeman A. L., de Jong W. K., Siemerink E. J. M., Staal A. J., Franken B., van Geffen W. H., Bootsma G. P. Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study European journal of cancer (Oxford, England 2020;141:171-184 [PubMed]
  • Oreel Tom H., Delespaul Philippe, Hartog Iris D., Henriques José P. S., Netjes Justine E., Vonk Alexander B. A., Lemkes Jorrit, Scherer-Rath Michael, van Laarhoven Hanneke W. M., Sprangers Mirjam A. G., Nieuwkerk Pythia T. Ecological momentary assessment versus retrospective assessment for measuring change in health-related quality of life following cardiac intervention Journal of Patient-Reported Outcomes 2020;4 (1) [PubMed]
  • Henselmans Inge, van Laarhoven Hanneke W M, van Maarschalkerweerd Pomme, de Haes Hanneke C J M, Dijkgraaf Marcel G W, Sommeijer Dirkje W, Ottevanger Petronella B, Fiebrich Helle-Brit, Dohmen Serge, Creemers Geert-Jan, de Vos Filip Y F L, Smets Ellen M A Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial oncologist 2020;25 (3):e578-e588 [PubMed]
  • Strijker Marin, Mackay Tara M., Bonsing Bert A., Bruno Marco J., van Eijck Casper H. J., de Hingh Ignace H. J. T., Koerkamp Bas Groot, van Laarhoven Hanneke W., Molenaar I. Quintus, van Santvoort Hjalmar C., van Tienhoven Geertjan, Wilmink Johanna W., Zeverijn Sako, Busch Olivier R., Besselink Marc G. Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group Annals of surgery 2020;271 (4):e102-e104 [PubMed]
  • van Roessel Stijn, van Veldhuisen Eran, Klompmaker Sjors, Janssen Quisette P., Abu Hilal Mohammed, Alseidi Adnan, Balduzzi Alberto, Balzano Gianpaolo, Bassi Claudio, Berrevoet Frederik, Bonds Morgan, Busch Olivier R., Butturini Giovanni, del Chiaro Marco, Conlon Kevin C., Falconi Massimo, Frigerio Isabella, Fusai Giuseppe K., Gagnière Johan, Griffin Oonagh, Hackert Thilo, Halimi Asif, Klaiber Ulla, Labori Knut J., Malleo Giuseppe, Marino Marco V., Mortensen Michael B., Nikov Andrej, Lesurtel Mickaël, Keck Tobias, Kleeff J. rg, Pandé Rupaly, Pfeiffer Per, Pietrasz D., Roberts Keith J., Sa Cunha Antonio, Salvia Roberto, Strobel Oliver, Tarvainen Timo, Bossuyt Patrick M., van Laarhoven Hanneke W. M., Wilmink Johanna W., Groot Koerkamp Bas, Besselink Marc G. Evaluation of Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX Treatment JAMA oncology 2020 [PubMed]
  • van Kleef J. J., van den Boorn H. G., Verhoeven R. H. A., Vanschoenbeek K., Abu-Hanna A., Zwinderman A. H., Sprangers M. A. G., van Oijen M. G. H., Schutter H. De, van Laarhoven H. W. M. External validation of the dutch SOURCE survival prediction model in belgian metastatic oesophageal and gastric cancer patients Cancers 2020;12 (4) [PubMed]
  • Anderegg Martinus C. J., Ruurda Jelle P., Gisbertz Suzanne S., Blom Rachel L. G. M., Sosef Meindert N., Wijnhoven Bas P. L., Hulshof Maarten C. C. M., Bergman Jacques J. G. H. M., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I. Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma European journal of surgical oncology 2020;46 (4):626-631 [PubMed]
  • Dijksterhuis Willemieke P. M., Stroes Charlotte I., Tan Wan-Ling, Ithimakin Suthinee, Calles Antonio, van Oijen Martijn G. H., Verhoeven Rob H. A., Barriuso Jorge, Oosting Sjoukje F., Ivankovic Daniela Kolarevic, Furness Andrew J. S., Bozovic-Spasojevic Ivana, Gomez-Roca Carlos, van Laarhoven Hanneke W. M. From presentation to paper: Gender disparities in oncological research International journal of cancer. Journal international du cancer 2020;146 (11):3011-3021 [PubMed]
  • van den Ende Tom, Hulshof Maarten C. C. M., van Berge Henegouwen Mark I., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Gastro-oesophageal junction: to FLOT or to CROSS? Acta oncologica (Stockholm, Sweden) 2020;59 (2):233-236 [PubMed]
  • Oreel Tom H., Nieuwkerk Pythia T., Hartog Iris D., Netjes Justine E., Vonk Alexander B. A., Lemkes Jorrit, van Laarhoven Hanneke W. M., Scherer-Rath Michael, Sprangers Mirjam A. G., Henriques José P. S. Gender differences in quality of life in coronary artery disease patients with comorbidities undergoing coronary revascularization PLoS ONE 2020;15 (6):e0234543 [PubMed]
  • Ykema Berbel L. M., Hoefnagel Sanne J. M., Rigter Lisanne S., Kodach Liudmila L., Meijer Gerrit A., van Leeuwen Flora E., Khan Hina N., Snaebjornsson Petur, Aleman Berthe M. P., Broeks Annegien, Meijer Sybren L., Wang Kenneth K., Carvalho Beatriz, Krishnadath Kausilia K., vanLeerdam Monique E., Meijer S. L., Hulshof M. C. C. M., Geijsen E. D., van Laarhoven H. W. M., van Berge Henegouwen M. I., Gisbertz S. S. Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases PLoS ONE 2020;15 (12 December) [PubMed]
  • de Clercq Nicolien C. Gut microbiota in host metabolism and cancer: From biological pathways to novel treatment strategies 2020. 217p. ISBN 9789464190670. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Nieuwdorp Max, Romijn J. A.; Co-supervisors: van Laarhoven Hanneke W. M., Prodan A.)
  • van den Boorn H. ctor G., Stroes Charlotte I., Zwinderman Aeilko H., Eshuis Wietse J., Hulshof Maarten C. C. M., van Etten-Jamaludin Faridi S., Sprangers Mirjam A. G., van Laarhoven Hanneke W. M. Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis Critical reviews in oncology/hematology 2020;154 [PubMed]
  • Dijksterhuis Willemieke P. M., Verhoeven Rob H. A., Slingerland Marije, Haj Mohammad Nadia, de Vos-Geelen Judith, Beerepoot Laurens V., van Voorthuizen Theo, Creemers Geert-Jan, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study International journal of cancer. Journal international du cancer 2020;146 (7):1889-1901 [PubMed]
  • Steins Anne, van Mackelenbergh Madelaine G., van der Zalm Amber P., Klaassen Remy, Serrels Bryan, Goris Sandrine G., Kocher Hemant M., Waasdorp Cynthia, de Jong Joan H., Tekin Cansu, Besselink Marc G., Busch Olivier R., van de Vijver Marc J., Verheij Joanne, Dijk Frederike, van Tienhoven Geertjan, Wilmink Johanna W., Medema Jan Paul, van Laarhoven Hanneke W. M., Bijlsma Maarten F. High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1 EMBO reports 2020;21 (5) [PubMed]
  • Dijksterhuis Willemieke P. M., Verhoeven Rob H. A., Pape Marieke, Slingerland Marije, Haj Mohammad Nadia, de Vos-Geelen Judith, Beerepoot Laurens V., van Voorthuizen Theo, Creemers Geert-Jan, Lemmens Valery E. P. P., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study European journal of cancer (Oxford, England 2020;139:107-118 [PubMed]
  • MacKay T. M., Smits F. J., Latenstein A. E. J., Bogte A., Bonsing B. A., Bos H., Bosscha K., Brosens L. A. A., Hol L., Busch O. R. C., Creemers G. J., Curvers W. L., den Dulk M., van Dieren S., van Driel L. M. J. W., Festen S., van Geenen E. J. M., van der Geest L. G., de Groot D. J. A., de Groot J. W. B., Haj Mohammad N., Haberkorn B. C. M., Haver J. T., van der Harst E., Hemmink G. J. M., de Hingh I. H., Hoge C., Homs M. Y. V., van Huijgevoort N. C., Jacobs M. A. J. M., Kerver E. D., Liem M. S. L., Los M., Lubbinge H., Luelmo S. A. C., de Meijer V. E., Mekenkamp L., Molenaar I. Q., van Oijen M. G. H., Patijn G. A., Quispel R., van Rijssen L. B., Römkens T. E. H., van Santvoort H. C., Schreinemakers J. M. J., Schut H., Seerden T., Stommel M. W. J., ten Tije A. J., Venneman N. G., Verdonk R. C., Verheij J., van Vilsteren F. G. I., de Vos-Geelen J., Vulink A., Wientjes C., Wit F., Wessels F. J., Zonderhuis B., van Werkhoven C. H., van Hooft J. E., van Eijck C. H. J., Wilmink J. W., van Laarhoven H. W. M., Besselink M. G. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): A multicenter stepped-wedge cluster randomized controlled trial Trials 2020;21 (1) [PubMed]
  • de Joode K., Dumoulin D. W., Engelen V., Bloemendal H. J., Verheij M., van Laarhoven H. W. M., Dingemans I. H., Dingemans A. C., van der Veldt A. A. M. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective European journal of cancer (Oxford, England 2020;136:132-139 [PubMed]
  • Latenstein Anouk E. J., Mackay Tara M., Creemers Geert-Jan, van Eijck Casper H. J., de Groot Jan Willem B., Haj Mohammad Nadia, Homs Marjolein Y. V., van Laarhoven Hanneke W. M., Molenaar I. Quintus, ten Tije Bert-Jan, de Vos-Geelen Judith, Besselink Marc G., van der Geest Lydia G. M., Wilmink Johanna W. Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis Acta oncologica (Stockholm, Sweden) 2020;59 (6):705-712 [PubMed]
  • Dijksterhuis Willemieke P. M., Verhoeven Rob H. A., Meijer Sybren L., Slingerland Marije, Haj Mohammad Nadia, de Vos-Geelen Judith, Beerepoot Laurens V., van Voorthuizen Theo, Creemers Geert-Jan, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study Gastric cancer 2020;23 (4):579-590 [PubMed]
  • Hagens Eliza R. C., Feenstra Minke L., van Egmond Maarten A., van Laarhoven Hanneke W. M., Hulshof Maarten C. C. M., Boshier Piers R., Low Donald E., van Berge Henegouwen Mark I., Gisbertz Suzanne S. Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE 2020;11 (3):756-767 [PubMed]
  • Rivera Debra, Kalleveen Irene, de Castro Catalina Arteaga, van Laarhoven Hanneke, Klomp Dennis, van der Kemp Wybe, Stoker Jaap, Nederveen Aart Inherently decoupled 1H antennas and 31P loops for metabolic imaging of liver metastasis at 7 T NMR in biomedicine 2020;33 (4) [PubMed]
  • van Laarhoven Hanneke W. M. Is chemotherapy for advanced or metastatic oesophageal squamous cell carcinoma no longer needed? lancet oncology 2020;21 (6):743-745
  • Jezerskyte E., Saadeh L. M., Hagens E. R. C., Sprangers M. A. G., Noteboom L., van Laarhoven H. W. M., Eshuis W. J., Hulshof M. C. C. M., van Berge Henegouwen M. I., Gisbertz S. S. Long-term health-related quality of life after McKeown and Ivor Lewis esophagectomy for esophageal carcinoma Diseases of the esophagus 2020;33 (11) [PubMed]
  • Jezerskyte E., Saadeh L. M., Hagens E. R. C., Sprangers M. A. G., Noteboom L., van Laarhoven H. W. M., Eshuis W. J., van Berge Henegouwen M. I., Gisbertz S. S. Long-Term Quality of Life After Total Gastrectomy Versus Ivor Lewis Esophagectomy World journal of surgery 2020;44 (3):838-848 [PubMed]
  • Jezerskyte E., Saadeh L. M., Hagens E. R. C., Sprangers M. A. G., Noteboom L., van Laarhoven H. W. M., Eshuis W. J., Hulshof M. C. C. M., van Berge Henegouwen M. I., Gisbertz S. S. Long-Term Quality of Life Following Transthoracic and Transhiatal Esophagectomy for Esophageal Cancer Journal of gastrointestinal surgery 2020 [PubMed]
  • le Large Tessa Ys, Mantini Giulia, Meijer Laura L., Pham Thang V., Funel Niccola, van Grieken Nicole Ct, Kok Bart, Knol Jaco, van Laarhoven Hanneke Wm, Piersma Sander R., Jimenez Connie R., Kazemier G., Giovannetti Elisa, Bijlsma Maarten F. Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets JCI insight 2020;5 (15) [PubMed]
  • van Velzen M. J. M., Derks S., van Grieken N. C. T., Haj Mohammad N., van Laarhoven H. W. M. MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma Cancer treatment reviews 2020;86 [PubMed]
  • van Egmond Maarten A., van der Schaaf Marike, Hagens Eliza R. C., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I., Haverkort Elizabeth B., Engelbert Raoul H. H., Gisbertz Suzanne S. Muscle Strength Is Associated With Muscle Mass in Patients With Esophageal Cancer Awaiting Surgery Journal of Geriatric Physical Therapy 2020;43 (2):82-88 [PubMed]
  • Muishout George, de la Croix Anne, Wiegers Gerard, van Laarhoven Hanneke W.M. Muslim doctors and decision making in palliative care: a discourse analysis Mortality 2020
  • Hartog Iris, Scherer-Rath Michael, Kruizinga Renske, Netjes Justine, Henriques José, Nieuwkerk Pythia, Sprangers Mirjam, van Laarhoven Hanneke Narrative meaning making and integration: Toward a better understanding of the way falling ill influences quality of life Journal of health psychology 2020;25 (6):738-754 [PubMed]
  • Mackay Tara M., Latenstein Anouk E. J., Bonsing Bert A., Bruno Marco J., van Eijck Casper H. J., Groot Koerkamp Bas, de Hingh Ignace H. J. T., Homs Marjolein Y. V., van Hooft Jeanin E., van Laarhoven Hanneke W., Molenaar I. Quintus, van Santvoort Hjalmar C., Stommel Martijn W. J., de Vos-Geelen Judith, Wilmink Johanna W., Busch Olivier R., van der Geest Lydia G., Besselink Marc G. Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up Pancreatology 2020;20 (8):1723-1731 [PubMed]
  • Latenstein Anouk E. J., van der Geest Lydia G. M., Bonsing Bert A., Groot Koerkamp Bas, Haj Mohammad Nadia, de Hingh Ignace H. J. T., de Meijer Vincent E., Molenaar Izaak Q., van Santvoort Hjalmar C., van Tienhoven Geertjan, Verheij Joanne, Vissers Pauline A. J., de Vos-Geelen Judith, Busch Olivier R., van Eijck Casper H. J., van Laarhoven Hanneke W. M., Besselink Marc G., Wilmink Johanna W. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma European journal of cancer (Oxford, England 2020;125:83-93 [PubMed]
  • Sanduleanu Sebastian, Jochems Arthur, Upadhaya Taman, Even Aniek J. G., Leijenaar Ralph T. H., Dankers Frank J. W. M., Klaassen Remy, Woodruff Henry C., Hatt Mathieu, Kaanders Hans J. A. M., Hamming-Vrieze Olga, van Laarhoven Hanneke W. M., Subramiam Rathan M., Huang Shao Hui, O'Sullivan Brian, Bratman Scott V., Dubois Ludwig J., Miclea Razvan L., di Perri Dario, Geets Xavier, Crispin-Ortuzar Mireia, Apte Aditya, Deasy Joseph O., Oh Jung Hun, Lee Nancy Y., Humm John L., Schöder Heiko, de Ruysscher Dirk, Hoebers Frank, Lambin Philippe Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures Radiotherapy and oncology 2020;153:97-105 [PubMed]
  • Slagter Astrid E., Tudela Benjamin, van Amelsfoort Romy M., Sikorska Karolina, van Sandick Johanna W., van de Velde Cornelis J. H., van Grieken Nicole C. T., Lind Pehr, Nordsmark Marianne, Putter Hein, Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Grootscholten Cecile, Braak Jeffrey P. B. M., Meershoek-Klein Kranenbarg Elma, Jansen Edwin P. M., Cats Annemieke, Verheij Marcel Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial European journal of cancer (Oxford, England 2020;130:146-154 [PubMed]
  • Klaassen Remy, Steins Anne, Gurney-Champion Oliver J., Bijlsma Maarten F., van Tienhoven Geertjan, Engelbrecht Marc R. W., van Eijck Casper H. J., Suker Mustafa, Wilmink Johanna W., Besselink Marc G., Busch Olivier R., de Boer Onno J., van de Vijver Marc J., Hooijer Gerrit K. J., Verheij Joanne, Stoker Jaap, Nederveen Aart J., van Laarhoven Hanneke W. M. Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience Molecular oncology 2020;14 (9):2176-2189 [PubMed]
  • Mackay Tara M., van Rijssen Lennart B., Andriessen Jurr O., Suker Mustafa, Creemers Geert-Jan, Eskens Ferry A., de Hingh Ignace H., van de Poll-Franse Lonneke V., Sprangers Mirjam A. G., Busch Olivier R., Wilmink Johanna W., van Eijck Casper H., Besselink Marc G., van Laarhoven Hanneke W. Patient Satisfaction and Quality of Life Before and After Treatment of Pancreatic and Periampullary Cancer: A Prospective Multicenter Study Journal of the National Comprehensive Cancer Network 2020;18 (6):704-711 [PubMed]
  • van de Poll-Franse Lonneke V., de Rooij Belle H., Horevoorts Nicole J. E., May Anne M., Vink Geraldine R., Koopman Miriam, van Laarhoven Hanneke W. M., Besselink Marc G., Oerlemans Simone, Husson Olga, Beijer Sandra, Ezendam Nicole P. M., Raijmakers Natasja J. H., Wollersheim Barbara M., Hoedjes Meeke, Siesling Sabine, van Eenbergen Mies C., Mols Floortje Perceived Care and Well-being of Patients with Cancer and Matched Norm Participants in the COVID-19 Crisis: Results of a Survey of Participants in the Dutch PROFILES Registry JAMA oncology 2020 [PubMed]
  • Stroes Charlotte I., Schokker Sandor, Creemers Aafke, Molenaar Remco J., Hulshof Maarten C. C. M., van der Woude Stephanie O., Bennink Roel J., Mathôt Ron A. A., Krishnadath Kausilia K., Punt Cornelis J. A., Verhoeven Rob H. A., van Oijen Martijn G. H., Creemers Geert-Jan, Nieuwenhuijzen Grard A. P., van der Sangen Maurice J. C., Beerepoot Laurens V., Heisterkamp Joos, Los Maartje, Slingerland Marije, Cats Annemieke, Hospers Geke A. P., Bijlsma Maarten F., van Berge Henegouwen Mark I., Meijer Sybren L., van Laarhoven Hanneke W. M. Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study Journal of clinical oncology 2020;38 (5):462-471 [PubMed]
  • Galeotti Alice Alessandra, Gentiluomo Manuel, Rizzato Cosmeri, Obazee Ofure, Neoptolemos John P., Pasquali Claudio, Nentwich Michael, Cavestro Giulia Martina, Pezzilli Raffaele, Greenhalf William, Holleczek Bernd, Schroeder Cornelia, Schöttker Ben, Ivanauskas Audrius, Ginocchi Laura, Key Timothy J., Hegyi Péter, Archibugi Livia, Darvasi Erika, Basso Daniela, Sperti Cosimo, Bijlsma Maarten F., Palmieri Orazio, Hlavac Viktor, Talar-Wojnarowska Renata, Mohelnikova-Duchonova Beatrice, Hackert Thilo, Vashist Yogesh, Strouhal Ondrej, Van Laarhoven Hanneke, Tavano Francesca, Lovecek Martin, Dervenis Christos, Izbéki Ferenc, Padoan Andrea, Małecka-Panas Ewa, Maiello Evaristo, Vanella Giuseppe, Capurso Gabriele, Izbicki Jakob R., Theodoropoulos George E., Jamroziak Krzysztof, Katzke Verena, Kaaks Rudolf, Mambrini Andrea, Papanikolaou Ioannis S., Szmola Richárd, Szentesi Andrea, Kupcinskas Juozas, Bursi Simona, Costello Eithne, Boggi Ugo, Milanetto Anna Caterina, Landi Stefano, Gazouli Maria, Vodickova Ludmila, Soucek Pavel, Gioffreda Domenica, Gemignani Federica, Brenner Hermann, Strobel Oliver, Büchler Markus, Vodicka Pavel, Paiella Salvatore, Canzian Federico, Campa Daniele Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction Journal of medical genetics 2020 [PubMed]
  • van den Ende Tom, van den Boorn H. ctor G., Hoonhout Nadine M., van Etten-Jamaludin Faridi S., Meijer Sybren L., Derks Sarah, de Gruijl Tanja D., Bijlsma Maarten F., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 2020;1874 (1) [PubMed]
  • van Kleef Jessy Joy, ter Veer Emil, van den Boorn H. ctor G., Schokker Sandor, Ngai Lok Lam, Prins Mariska J., Mohammad Nadia Haj, van de Poll-Franse Lonneke V., Zwinderman Aeilko H., van Oijen Martijn G. H., Sprangers Mirjam A. G., van Laarhoven Hanneke W. M. Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer: Systematic Review and Meta-Analysis: systematic review and meta-analysis Journal of the National Cancer Institute 2020;112 (1):12-29 [PubMed]
  • Klaassen Remy Quantitative imaging to characterize pancreatic and esophagogastric cancer 2020. 263p. ISBN 9789402819410. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven Hanneke W. M., Nederveen Aart J.; Co-supervisors: Bijlsma Maarten F., Bennink Roel J.)
  • Steins Anne, Klaassen Remy, Jacobs Igor, Schabel Matthias C., van Lier Monique G. J. T. B., Ebbing Eva A., Hectors Stefanie J., Tas Sander W., Maracle Chrissta X., Punt Cornelis J. A., Siebes Maria, Bergman Jacques J. G. H. M., Medema Jan Paul, Wilmink Johanna W., Mathot Ron A. A., Strijkers Gustav J., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma Molecular oncology 2020;14 (4):704-720 [PubMed]
  • MacKay Tara M., Latenstein E. J., Sprangers Mirjam A. G., van der Geest Lydia G., Creemers Geert-Jan, van Dieren Susan, de Groot Jan-Willem B., Koerkamp Bas Groot, de Hingh Ignace H., Homs Marjolein Y. V., de Jong Evelien J. M., Molenaar I. Quintus, Patijn Gijs A., van de Poll-Franse Lonneke V., van Santvoort Hjalmar C., de Vos-Geelen Judith, Wilmink Johanna W., van Eijck Casper H., Besselink Marc G., van Laarhoven Hanneke W. M. Relationship between quality of life and survival in patients with pancreatic and periampullary cancer: A multicenter cohort analysis Journal of the National Comprehensive Cancer Network 2020;18 (10):1354-1363 [PubMed]
  • Liu Dajia, Steins Anne, Klaassen Remy, van der Zalm Amber P., Bennink Roel J., van Tienhoven Geertjan, Besselink Marc G., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Soluble compounds released by hypoxic stroma confer invasive properties to pancreatic ductal adenocarcinoma Biomedicines 2020;8 (11):1-23 [PubMed]
  • Ebenau Anne, Groot Marieke, Visser Anja, van Laarhoven Hanneke W. M., van Leeuwen René, Garssen Bert Spiritual care by nurses in curative oncology: a mixed-method study on patients’ perspectives and experiences Scandinavian journal of caring sciences 2020;34 (1):96-107 [PubMed]
  • Mackay Tara M. The Dutch Pancreatic Cancer Project: Towards nationwide improvement of outcomes 2020. 318p. ISBN 9789463807975. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Besselink Marc G. H., van Eijck C. H. J.; Co-supervisors: van Laarhoven Hanneke W. M., Busch Olivier R. C.)
  • Strijker Marin The Dutch Pancreatic Cancer Project: Tools for a tailored approach to pancreatic and periampullary cancer treatment 2020. 293p. ISBN 9789463807869. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Besselink Marc G. H., van Laarhoven Hanneke W. M.; Co-supervisors: Eijck Casper H. J., Bijlsma Maarten F.)
  • van der Velden Naomi C. A., Meijers Maartje C., Han Paul K. J., van Laarhoven Hanneke W. M., Smets Ellen M. A., Henselmans Inge The Effect of Prognostic Communication on Patient Outcomes in Palliative Cancer Care: a Systematic Review Current treatment options in oncology 2020;21 (5) [PubMed]
  • Bosman J. T., Bood Z. M., Scherer-Rath M., Dörr H., Christophe N., Sprangers M. A. G., van Laarhoven H. W. M. The effects of art therapy on anxiety, depression, and quality of life in adults with cancer: a systematic literature review Supportive care in cancer 2020 [PubMed]
  • Mackay Tara M., Smits F. Jasmijn, Roos Daphne, Bonsing Bert A., Bosscha Koop, Busch Olivier R., Creemers Geert-Jan, van Dam Ronald M., van Eijck Casper H. J., Gerhards Michael F., de Groot Jan Willem B., Groot Koerkamp Bas, Haj Mohammad Nadia, van der Harst Erwin, de Hingh Ignace H. J. T., Homs Marjolein Y. V., Kazemier Geert, Liem Mike S. L., de Meijer Vincent E., Molenaar I. Quintus, Nieuwenhuijs Vincent B., van Santvoort Hjalmar C., van der Schelling George P., Stommel Martijn W. J., ten Tije Albert Jan, de Vos-Geelen Judith, Wit Fennie, Wilmink Johanna W., van Laarhoven Hanneke W. M., Besselink Marc G. The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis HPB: The official journal of the International Hepato Pancreato Biliary Association 2020;22 (2):233-240 [PubMed]
  • Steins Anne The role of the tumor microenvironment in tumors of the upper gastrointestinal tract 2020. 311p. ISBN 9789402820980. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven Hanneke W. M., Medema Jan P.; Co-supervisor: Bijlsma Maarten F.)
  • Mulder F. I., Hovenkamp A., van Laarhoven H. W. M., Büller H. R., Kamphuisen P. W., Hulshof M. C. C. M., van Berge Henegouwen M. I., Middeldorp S., van Es N. Thromboembolic and bleeding complications in patients with oesophageal cancer British journal of surgery 2020;107 (10):1324-1333 [PubMed]
  • Dijk Frederike, Veenstra Veronique L., Soer Eline C., Dings Mark P. G., Zhao Lan, Halfwerk Johannes B., Hooijer Gerrit K., Damhofer Helene, Marzano Marco, Steins Anne, Waasdorp Cynthia, Busch Olivier R., Besselink Marc G., Tol Johanna A., Welling Lieke, van Rijssen Lennart B., Klompmaker Sjors, Wilmink Hanneke W., van Laarhoven Hanneke W., Medema Jan Paul, Vermeulen Louis, van Hooff Sander R., Koster Jan, Verheij Joanne, van de Vijver Marc J., Wang Xin, Bijlsma Maarten F. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems Scientific reports 2020;10 (1):337 [PubMed]
  • Slagter Astrid E., Sikorska Karolina, Grootscholten Cecile, van Laarhoven Hanneke W. M., Lind Pehr, Nordsmark Marianne, Meershoek-Klein Kranenbarg Elma, van de Velde Cornelis J. H., van Grieken Nicole C. T., van Sandick Johanna W., Jansen Edwin P. M., Verheij Marcel, Cats Annemieke Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial Cancer medicine 2020;9 (18):6609-6616 [PubMed]
  • Mulder Frits I, Horvàth-Puhó Erzsébet, van Es Nick, van Laarhoven Hanneke, Pedersen Lars, Moik Florian, Ay Cihan, Buller Harry R, Toft Sørensen Henrik Venous thromboembolism in cancer patients: a population-based cohort study Blood 2020 [PubMed]
  • Leal Alessandro, van Grieken Nicole C. T., Palsgrove Doreen N., Phallen Jillian, Medina Jamie E., Hruban Carolyn, Broeckaert Mark A. M., Anagnostou Valsamo, Adleff Vilmos, Bruhm Daniel C., Canzoniero Jenna V., Fiksel Jacob, Nordsmark Marianne, Warmerdam Fabienne A. R. M., Verheul Henk M. W., van Spronsen Dick Johan, Beerepoot Laurens V., Geenen Maud M., Portielje Johanneke E. A., Jansen Edwin P. M., van Sandick Johanna, Meershoek-Klein Kranenbarg Elma, van Laarhoven Hanneke W. M., van der Peet Donald L., van de Velde Cornelis J. H., Verheij Marcel, Fijneman Remond, Scharpf Robert B., Meijer Gerrit A., Cats Annemieke, Velculescu Victor E. White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer Nature communications 2020;11 (1) [PubMed]

2019

  • Hidding Janine T., Beurskens Carien H. G., de Vries Marijke T., Nijhuis-van der Sanden Maria W. G., van Laarhoven Hanneke W. M., van der Wees Philip J. Accuracy of a single measurement site for self-monitoring of patients with breast cancer at risk for lymphedema Physiotherapy Theory and Practice 2019;35 (12):1322-1327 [PubMed]
  • van Veldhuisen Eran, Walma Marieke S., van Rijssen L. Bengt, Busch Olivier R., Bruijnen Rutger C. G., van Delden Otto M., Mohammad Nadia Haj, de Hingh Ignace H., Yo Lonneke S., van Laarhoven Hanneke W., van Leeuwen Maarten S., Nio C. Yung, van Santvoort Hjalmar C., de Vries Jan, Wessels Frank J., Wilmink Johanna W., Molenaar I. Quintus, Besselink Marc G., van Lienden Krijn P. Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer following FOLFIRINOX chemotherapy (IMAGE): a prospective multicenter study HPB: The official journal of the International Hepato Pancreato Biliary Association 2019;21 (10):1385-1392 [PubMed]
  • de Groot Stefanie, Pijl Hanno, Charehbili Ayoub, van de Ven Saskia, Smit Vincent T. H. B. M., Meershoek-Klein Kranenbarg Elma, Heijns Joan B., van Warmerdam Laurence J. C., Kessels Lonneke W., Dercksen M. Wouter, Pepels Manon J. A. E., van Laarhoven Hanneke W. M., Vriens Birgit E. P. J., Putter Hein, Fiocco Marta, Liefers Gerrit-Jan, van der Hoeven Jacobus J. M., Nortier Johan W. R., Kroep Judith R. Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01) Breast cancer research 2019;21 (1) [PubMed]
  • de Kruif J. Th. C. M., Visser M., van den Berg M. M. G. A., Derks M. J. M., de Boer M. R., van Laarhoven H. W. M., de Vries J. H. M., de Vries Y. C., Kampman E., Winkels R. W., Westerman M. J. A longitudinal mixed methods study on changes in body weight, body composition, and lifestyle in breast cancer patients during chemotherapy and in a comparison group of women without cancer: Study protocol BMC cancer 2019;19 (1) [PubMed]
  • Kruizinga Renske, Scherer-Rath Michael, Schilderman Johannes B. AM, Hartog Iris D., van der Loos Jacoba P. M., Kotzé Hantie P., Westermann Anneke M., Klümpen Heinz-Josef, Kortekaas Francesco, Grootscholten Cecile, Bossink Frans, Schrama Jolanda, van de Vrande Willem, Schrama Natascha A. WP, Blokland Willem, de Vos Filip Y. FL, Kuin Annemieke, Meijer Wim G., van Oijen Martijn G. H., Sprangers Mirjam A. G., van Laarhoven Hanneke W. M. An assisted structured reflection on life events and life goals in advanced cancer patients: Outcomes of a randomized controlled trial (Life InSight Application (LISA) study) Palliative medicine 2019;33 (2):221-231 [PubMed]
  • van Kesteren Z., van der Horst A., Gurney-Champion O. J., Bones I., Tekelenburg D., Alderliesten T., van Tienhoven G., Klaassen R., van Laarhoven H. W. M., Bel A. A novel amplitude binning strategy to handle irregular breathing during 4DMRI acquisition: Improved imaging for radiotherapy purposes Radiation oncology (London, England) 2019;14 (1) [PubMed]
  • Dijksterhuis Willemieke P.M., Pruijt Maarten J., van der Woude Stephanie O., Klaassen Remy, Kurk Sophie A., van Oijen Martijn G.H., van Laarhoven Hanneke W.M. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE 2019;10 (1):199-206 [PubMed]
  • Mackay Tara M., van Erning Felice N., van der Geest Lydia G. M., de Groot Jan Willem B., Haj Mohammad Nadia, Lemmens Valery E., van Laarhoven Hanneke W., Besselink Marc G., Wilmink Johanna W. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis European journal of cancer (Oxford, England 2019;106:99-105 [PubMed]
  • Rohde Gudrun Elin, Young Teresa, Winstanley Julie, Arraras Juan I., Black Kath, Boyle Fran, Bredart Anne, Costantini Anna, Guo Jingbo, Irarrazaval Maria E., Kobayashi Kunihiko, Kruizinga Renske, Navarro Mariana, Omidvari Sepideh, Serpentini Samantha, Spry Nigel, van Laarhoven Hanneke, Yang Grace, Vivat Bella Associations between sex, age and spiritual well-being scores on the EORTC QLQ-SWB32 for patients receiving palliative care for cancer: A further analysis of data from an international validation study European journal of cancer care 2019 [PubMed]
  • van den Berg Maaike M. G. A., Kok Dieuwertje E., Posthuma Liesbeth, Kamps Lisette, Kelfkens Celine S., Buist Nicole, Geenen Maud, Haringhuizen Annebeth, Heijns Joan B., van Lieshout Rianne H. M. A., Los Maartje, Sommeijer Dirkje W., Timmer-Bonte Johanna N. H., de Kruif Anja Th. C. M., van Laarhoven Hanneke W. M., Kampman Ellen, Winkels Renate M. Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy Breast cancer research and treatment 2019;173 (2):475-481 [PubMed]
  • Bulten Ben F., Sollini Martina, Boni Roberto, Massri Katrin, de Geus-Oei Lioe-Fee, van Laarhoven Hanneke W. M., Slart Riemer H. J. A., Erba Paola A. Cardiac molecular pathways influenced by doxorubicin treatment in mice Scientific reports 2019;9 (1) [PubMed]
  • Kok Dieuwertje E., van den Berg Maaike M. G. A., Posthuma Liesbeth, van ’t Erve Iris, van Duijnhoven Fränzel J. B., de Roos Wilfred K., Grosfeld Sissi, Los Maartje, Sommeijer Dirkje W., van Laarhoven Hanneke W. M., Winkels Renate M., Kampman Ellen Changes in Circulating Levels of 25-hydroxyvitamin D3 in Breast Cancer Patients Receiving Chemotherapy Nutrition and cancer 2019;71 (5):756-766 [PubMed]
  • Akkermans Aranka, Henkemans Francisca Snoeck, Labrie Nanon, Henselmans Inge, van Laarhoven Hanneke W. M. Characteristics of argumentation in consultations about palliative systemic treatment for advanced cancer: An observational content analysisin: Frans H. van Eemeren, Bart Garssen, editors. Argumentation in Actual Practice. John Benjamins Publishing Company; 2019. p. 237-266, ISBN 9789027204028|
  • Steins Anne, Ebbing Eva A., Creemers Aafke, van der Zalm Amber P., Jibodh Rajni A., Waasdorp Cynthia, Meijer Sybren L., van Delden Otto M., Krishnadath Kausilia K., Hulshof Maarten C. C. M., Bennink Roelof J., Punt Cornelis J. A., Medema Jan Paul, Bijlsma Maarten F., van Laarhoven Hanneke W. M. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma International journal of cancer. Journal international du cancer 2019;145 (10):2792-2803 [PubMed]
  • van Mackelenbergh Madelaine G., Stroes Charlotte I., Spijker René, van Eijck Casper H. J., Wilmink Johanna W., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Clinical trials targeting the stroma in pancreatic cancer: A systematic review and meta-analysis Cancers 2019;11 (5) [PubMed]
  • van den Ende Tom, Abe Nijenhuis Frank A., van den Boorn H. ctor G., ter Veer Emil, Hulshof Maarten C. C. M., Gisbertz Suzanne S., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis Frontiers in oncology 2019;9 [PubMed]
  • Krikken Erwin, van der Kemp Wybe J. M., Khlebnikov Vitaliy, van Dalen Thijs, Los Maartje, van Laarhoven Hanneke W. M., Luijten Peter R., van den Bosch Maurice A. A. J., Klomp Dennis W. J., Wijnen Jannie P. Contradiction between amide-CEST signal and pH in breast cancer explained with metabolic MRI NMR in biomedicine 2019;32 (8) [PubMed]
  • van Rijssen Lennart B., Gerritsen Arja, Henselmans Inge, Sprangers Mirjam A., Jacobs Marc, Bassi Claudio, Busch Olivier R., Fernández-del Castillo Carlos, Fong Zhi Ven, He Jin, Jang Jin-Young, Javed Ammar A., Kim Sun-Whe, Maggino Laura, Mitra Abhishek, Ostwal Vikas, Pellegrini Silvia, Shrikhande Shailesh V., Wilmink Johanna W., Wolfgang Christopher L., van Laarhoven Hanneke W., Besselink Marc G. Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care Providers Annals of surgery 2019;270 (1):158-164 [PubMed]
  • van den Ende Tom, Menting Stef P, Ambarus Carmen A, van Oijen Martijn G H, van Laarhoven Hanneke W M Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye oncologist 2019;24 (4):e149-e153 [PubMed]
  • Hagens Eliza R. C., van Berge Henegouwen Mark I., van Sandick Johanna W., Cuesta Miguel A., van der Peet Donald L., Heisterkamp Joos, Nieuwenhuijzen Grard A. P., Rosman Camiel, Scheepers Joris J. G., Sosef Meindert N., van Hillegersberg Richard, Lagarde Sjoerd M., Nilsson Magnus, Räsänen Jari, Nafteux Philippe, Pattyn Piet, Hölscher Arnulf H., Schröder Wolfgang, Schneider Paul M., Mariette Christophe, Castoro Carlo, Bonavina Luigi, Rosati Riccardo, de Manzoni Giovanni, Mattioli Sandro, Garcia Josep Roig, Pera Manuel, Griffin Michael, Wilkerson Paul, Chaudry M. Asif, Sgromo Bruno, Tucker Olga, Cheong Edward, Moorthy Krishna, Walsh Thomas N., Reynolds John, Tachimori Yuji, Inoue Haruhiro, Matsubara Hisahiro, Kosugi Shin-Ichi, Chen Haiquan, Law Simon Y. K., Pramesh C. S., Puntambekar Shailesh P., Murthy Sudish, Linden Philip, Hofstetter Wayne L., Kuppusamy Madhan K., Shen K. Robert, Darling Gail E., Sabino Flávio D., Grimminger Peter P., Meijer Sybren L., Bergman Jacques J. G. H. M., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Mearadji Banafsche, Bennink Roel J., Annema Jouke T., Dijkgraaf Marcel G. W., Gisbertz Suzanne S. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: Study protocol of a multinational observational study BMC cancer 2019;19 (1) [PubMed]
  • Krikken Erwin, van der Kemp Wybe J. M., van Diest Paul J., van Dalen Thijs, van Laarhoven Hanneke W. M., Luijten Peter R., Klomp Dennis W. J., Wijnen Jannie P. Early detection of changes in phospholipid metabolism during neoadjuvant chemotherapy in breast cancer patients using phosphorus magnetic resonance spectroscopy at 7T NMR in biomedicine 2019 [PubMed]
  • Gurney-Champion Oliver J., Collins David J., Wetscherek Andreas, Rata Mihaela, Klaassen Remy, van Laarhoven Hanneke W. M., Harrington Kevin J., Oelfke Uwe, Orton Matthew R. Erratum: Principal component analysis for fast and model-free denoising of multi b-value diffusion-weighted MR images (Physics in Medicine and Biology (2019) 64 (05015) DOI: 10.1088/1361-6560/ab318a) Physics in medicine and biology 2019;64 (17)
  • Araghi Sadaf Oliai, Kiefte-de Jong Jessica C., van Dijk Suzanne C., Swart Karin M. A., van Laarhoven Hanneke W., van Schoor Natasja M., de Groot Lisette C. P. G. M., Lemmens Valery, Stricker Bruno H., Uitterlinden Andre G., van der Velde Nathalie Folic acid and Vitamin B12 supplementation and the risk of cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial Cancer epidemiology, biomarkers & prevention 2019;28 (2):275-282 [PubMed]
  • Campa Daniele, Matarazzi Martina, Greenhalf William, Bijlsma Maarten, Saum Kai-Uwe, Pasquali Claudio, van Laarhoven Hanneke, Szentesi Andrea, Federici Francesca, Vodicka Pavel, Funel Niccola, Pezzilli Raffaele, Bueno-de-Mesquita H. Bas, Vodickova Ludmila, Basso Daniela, Obazee Ofure, Hackert Thilo, Soucek Pavel, Cuk Katarina, Kaiser J. rg, Sperti Cosimo, Lovecek Martin, Capurso Gabriele, Mohelnikova-Duchonova Beatrice, Khaw Kay-Tee, König Anna-Katharina, Kupcinskas Juozas, Kaaks Rudolf, Bambi Franco, Archibugi Livia, Mambrini Andrea, Cavestro Giulia Martina, Landi Stefano, Hegyi P. ter, Izbicki Jakob R., Gioffreda Domenica, Zambon Carlo Federico, Tavano Francesca, Talar-Wojnarowska Renata, Jamroziak Krzysztof, Key Timothy J., Fave Gianfranco Delle, Strobel Oliver, Jonaitis Laimas, Andriulli Angelo, Lawlor Rita T., Pirozzi Felice, Katzke Verena, Valsuani Chiara, Vashist Yogesh K., Brenner Hermann, Canzian Federico Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study International journal of cancer. Journal international du cancer 2019;144 (6):1275-1283 [PubMed]
  • Hartog Iris D., Willems Dick L., van den Hout Wilbert B., Scherer-Rath Michael, Oreel Tom H., Henriques José P. S., Nieuwkerk Pythia T., van Laarhoven Hanneke W. M., Sprangers Mirjam A. G. Influence of response shift and disposition on patient-reported outcomes may lead to suboptimal medical decisions: a medical ethics perspective BMC medical ethics 2019;20 (1):61 [PubMed]
  • Kuninty Praneeth R., Bansal Ruchi, de Geus Susanna W. L., Mardhian Deby F., Schnittert Jonas, van Baarlen Joop, Storm Gert, Bijlsma Maarten F., van Laarhoven Hanneke W., Metselaar Josbert M., Kuppen Peter J. K., Vahrmeijer Alexander L., Östman Arne, Sier Cornelis F. M., Prakash Jai ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer Science advances 2019;5 (9) [PubMed]
  • van Hilst Jony, de Rooij Thijs, Bosscha Koop, Brinkman David J., van Dieren Susan, Dijkgraaf Marcel G., Gerhards Michael F., de Hingh Ignace H., Karsten Tom M., Lips Daniel J., Luyer Misha D., Busch Olivier R., Festen Sebastiaan, Besselink Marc G., Marsman Hendrik A., van Gulik Thomas M., Wicherts Dennis A., Eshuis Wietse J., Stibbe Luna A., Nieveen van Dijkum Els J. M., van Hooft Janine E., Fockens Paul, van Laarhoven Hanneke W., Wilmink Johanna W., van de Vijver Marcel J., Bijlsma Maarten F., Verheij Joanne, Nio C. Yung, van Lienden Krijn P., van Tienhoven Geertjan, Schoorlemmer Annuska, Creemers Geert-Jan, van Eijck Casper H. J., Groot Koerkamp Bas, Bruno Marco J., Eskens Ferry, Nuyttens Joost J., Pek Chulja, van der Schelling George P., Swijnenburg Rutger J., Brosens Lodewijk A., Roos Daphne, van Santvoort Hjalmar C., Haj Mohammad Nadia, Daams Freek, van Rijssen L. Bengt, van Veldhuisen Eran, Scholten Lianne, Strijker Marin, Korrel Maarten Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial lancet. Gastroenterology & hepatology 2019;4 (3):199-207 [PubMed]
  • ter Voert Edwin E. G. W., Heijmen Linda, van Asten Jack J. A., Wright Alan J., Nagtegaal Iris D., Punt Cornelis J. A., de Wilt Johannes H. W., van Laarhoven Hanneke W. M., Heerschap Arend Levels of choline-containing compounds in normal liver and liver metastases of colorectal cancer as recorded by 1H MRS NMR in biomedicine 2019;32 (1) [PubMed]
  • Bood Zarah M., Scherer-Rath Michael, Sprangers Mirjam A. G., Timmermans Liesbeth, van Wolde Ellen, Cristancho Sayra M., Heyning Fenna, Russel Silvia, van Laarhoven Hanneke W. M., Helmich Esther Living with advanced cancer: Rich Pictures as a means for health care providers to explore the experiences of advanced cancer patients Cancer medicine 2019;8 (11):4957-4966 [PubMed]
  • de Vries Y. C., Boesveldt S., Kampman E., de Graaf C., Winkels R. M., van Laarhoven H. W. M. Low reported taste function is associated with low preference for high protein products in advanced oesophagogastric cancer patients undergoing palliative chemotherapy Clinical nutrition (Edinburgh, Scotland) 2019;38 (1):472-475 [PubMed]
  • Takeuchi Madoka, Ajani Jaffer A., Fang Xuemin, Pfeiffer Per, Takeuchi Masahiro, van Laarhoven Hanneke W. M. Meta-enrichment analyses to identify advanced gastric cancer patients who achieve a higher response to s-1/cisplatin Cancers 2019;11 (6) [PubMed]
  • Weeseman Yvonne, van Laarhoven Hanneke, Scherer-Rath Michael Modes of Narrative Integration of Experiences of Contingency in Highly Sensitive Children: A Qualitative Pilot Study Journal of Empirical Theology 2019;32 (2):211-231
  • Willemsen Annelieke E. C. A. B., Krausz Sarah, Ligtenberg Marjolijn J. L., Grünberg Katrien, Groen Harry J. M., Voest Emile E., Cuppen Edwin P. J. G., van Laarhoven Hanneke W. M., van Herpen Carla M. L. Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations British journal of cancer 2019;121 (1):34-36 [PubMed]
  • Rovers Koen P., Bakkers Checca, Simkens Geert A. A. M., Burger Jacobus W. A., Nienhuijs Simon W., Creemers Geert-Jan M., Thijs Anna M. J., Brandt-Kerkhof Alexandra R. M., Madsen Eva V. E., Ayez Ninos, de Boer Nadine L., van Meerten Esther, Tuynman Jurriaan B., Kusters Miranda, Sluiter Nina R., Verheul Henk M. W., van der Vliet Hans J., Wiezer Marinus J., Boerma Djamila, Wassenaar Emma C. E., Los Maartje, Hunting Cornelis B., Aalbers Arend G. J., Kok Niels F. M., Kuhlmann Koert F. D., Boot Henk, Chalabi Myriam, Kruijff Schelto, Been Lukas B., van Ginkel Robert J., de Groot Derk Jan A., Fehrmann Rudolf S. N., de Wilt Johannes H. W., Bremers Andreas J. A., de Reuver Philip R., Radema Sandra A., Herbschleb Karin H., van Grevenstein Wilhelmina M. U., Witkamp Arjen J., Koopman Miriam, Haj Mohammad Nadia, van Duyn Eino B., Mastboom Walter J. B., Mekenkamp Leonie J. M., Nederend Joost, Lahaye Max J., Snaebjornsson Petur, Verhoef Cornelis, van Laarhoven Hanneke W. M., Zwinderman Aeilko H., Bouma Jeanette M., Kranenburg Onno, van 't Erve Iris, Fijneman Remond J. A., Dijkgraaf Marcel G. W., Hemmer Patrick H. J., Punt Cornelis J. A., Tanis Pieter J., de Hingh Ignace H. J. T. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: Protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6) BMC cancer 2019;19 (1) [PubMed]
  • Schokker Sandor, van der Woude Stephanie O., van Kleef Jessy Joy, van Zoen Daan J., van Oijen Martijn G. H., Mearadji Banafsche, Beenen Ludo F. M., Stroes Charlotte I., Waasdorp Cynthia, Jibodh R. Aarti, Creemers Aafke, Meijer Sybren L., Hooijer Gerrit K. J., Punt Cornelis J. A., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Phase I Dose escalation study with expansion cohort of the addition of nab-paclitaxel to capecitabine and oxaliplatin (CapOx) as first-line treatment of metastatic esophagogastric adenocarcinoma (ACTION study) Cancers 2019;11 (6) [PubMed]
  • van Putten Margreet, Lemmens Valery E. P. P., van Laarhoven Hanneke W. M., Pruijt Hans F. M., Nieuwenhuijzen Grard A. P., Verhoeven Rob H. A. Poor compliance with perioperative chemotherapy for resectable gastric cancer and its impact on survival European journal of surgical oncology 2019;45 (10):1926-1933 [PubMed]
  • Daamen L. A., Groot V. P., Intven M. P. W., Besselink M. G., Busch O. R., Koerkamp B. Groot, Mohammad N. Haj, Hermans J. J., van Laarhoven H. W. M., Nuyttens J. J., Wilmink J. W., van Santvoort H. C., Molenaar I. Q., Stommel M. W. J. Postoperative surveillance of pancreatic cancer patients European journal of surgical oncology 2019;45 (10):1770-1777 [PubMed]
  • Gurney-Champion Oliver J., Collins David J., Wetscherek Andreas, Rata Mihaela, Klaassen Remy, van Laarhoven Hanneke W. M., Harrington Kevin J., Oelfke Uwe, Orton Matthew R. Principal component analysis for fast and model-free denoising of multi b-value diffusion-weighted MR images Physics in medicine and biology 2019;64 (10) [PubMed]
  • van den Ende Tom, Veer Emilter, Mali Rosa M. A., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Prognostic and predictive factors for the curative treatment of esophageal and gastric cancer in randomized controlled trials: A systematic review and meta-analysis Cancers 2019;11 (4) [PubMed]
  • Henselmans Inge, Brugel Sabrina D, de Haes Hanneke C J M, Wolvetang Kim J A, de Vries Laura M, Pieterse Arwen H, Baas-Thijssen Monique C M, de Vos Filip Y F, van Laarhoven Hanneke W M, Smets Ellen M A Promoting shared decision making in advanced cancer: Development and piloting of a patient communication aid Patient education and counseling 2019;102 (5):916-923 [PubMed]
  • le Large Tessa Ya Sung, el Hassouni Btissame, Funel Niccola, Kok Bart, Piersma Sander R., Pham Thang V., Olive Kenneth P., Kazemier Geert, van Laarhoven Hanneke W. M., Jimenez Connie R., Bijlsma Maarten F., Giovannetti Elisa Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment Therapeutic advances in medical oncology 2019;11 [PubMed]
  • Hartog Iris D., Scherer-Rath Michael, Oreel Tom H., Netjes Justine E., Henriques José P. S., Lemkes Jorrit, Vonk Alexander, Sprangers Mirjam A. G., Nieuwkerk Pythia T., van Laarhoven Hanneke W. M. Reconstructing Disruptive Life Events Using the RE-LIFE Questionnaire: Further Validation of the 'Narrative Meaning Making of Life Events' Model Using Multiple Mediation Analysis Journal of Empirical Theology 2019;32 (2):251-280
  • Mokadem I., Dijksterhuis W. P. M., van Putten M., Heuthorst L., de Vos-Geelen J. M., Haj Mohammad N., Nieuwenhuijzen G. A. P., van Laarhoven H. W. M., Verhoeven R. H. A. Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study Gastric cancer 2019;22 (6):1263-1273 [PubMed]
  • Draper Emma J., Hillen Marij A., Moors Marleen, Ket Johannes C. F., van Laarhoven Hanneke W. M., Henselmans Inge Relationship between physicians’ death anxiety and medical communication and decision-making: A systematic review Patient education and counseling 2019;102 (2):266-274 [PubMed]
  • Hillen Marij, Smets Elisabeth, Woei-A-Jin F. J. Sherida, van Maarschalkerweerd Pomme, van Laarhoven Hanneke, Sommeijer Dirkje Second opinions op verzoek van de patiënt - de visie van medisch oncologen en hematologen Nederlands tijdschrift voor hematologie 2019;16 (6):280-287
  • Hillen Marij, Smets Elisabeth, Woei-A-Jin F. J. S. H., van Maarschalkerweerd Pomme E. A., van Laarhoven Hanneke, Sommeijer Dirkje Second opinions op verzoek van de patiënt – de visie van medisch oncologen en hematologen Nederlands tijdschrift voor oncologie 2019;16:131-138
  • van den Boorn Héctor G, Abu-Hanna Ameen, Ter Veer Emil, van Kleef Jessy Joy, Lordick Florian, Stahl Michael, Ajani Jaffer A, Guimbaud Rosine, Park Se Hoon, Dutton Susan J, Bang Yung-Jue, Boku Narikazu, Mohammad Nadia Haj, Sprangers Mirjam A G, Verhoeven Rob H A, Zwinderman Aeilko H, van Oijen Martijn G H, van Laarhoven Hanneke W M SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer Cancers 2019;11 (2):E187 [PubMed]
  • Ebbing Eva A., van der Zalm Amber P., Steins Anne, Creemers Aafke, Hermsen Simone, Rentenaar Rosa, Klein Michelle, Waasdorp Cynthia, Hooijer Gerrit K. J., Meijer Sybren L., Krishnadath Kausilia K., Punt Cornelis J. A., van Berge Henegouwen Mark I., Gisbertz Suzanne S., van Delden Otto M., Hulshof Maarten C. C. M., Medema Jan Paul, van Laarhoven Hanneke W. M., Bijlsma Maarten F. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma Proceedings of the National Academy of Sciences of the United States of America 2019;116 (6):2237-2242 [PubMed]
  • ter Veer Emil Systematic approach to unify evidence for advanced upper gastrointestinal cancer treatment 2019. 555p. ISBN 9789463325622. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van Laarhoven H. W. M.; Co-supervisor: van Oijen M. G. H.)
  • Strijker M, Chen J W, Mungroop T H, Jamieson N B, van Eijck C H, Steyerberg E W, Wilmink J W, Groot Koerkamp B, van Laarhoven H W, Besselink M G Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer British journal of surgery 2019;106 (4):342-354 [PubMed]
  • Nguyen Minh Hao, Smets Ellen Ma, Bol Nadine, Loos Eugène F., van Laarhoven Hanneke Wm, Geijsen Debby, van Berge Henegouwen Mark I., Tytgat Kristien Maj, van Weert Julia Cm Tailored Web-Based Information for Younger and Older Patients with Cancer: Randomized Controlled Trial of a Preparatory Educational Intervention on Patient Outcomes Journal of medical Internet research 2019;21 (10):e14407 [PubMed]
  • van Rijssen Lennart B. The Dutch Pancreatic Cancer Project: Optimization of clinical research in pancreatic cancer 2019. 310p. ISBN 9789463801607. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Busch O. R. C. , van Laarhoven H. W. M.; Co-supervisors: Besselink M. G. H. , Eijck C. H. J.)
  • Oreel Tom H., Borsboom Denny, Epskamp Sacha, Hartog Iris D., Netjes Justine E., Nieuwkerk Pythia T., Henriques José P. S., Scherer-Rath Michael, van Laarhoven Hanneke W. M., Sprangers Mirjam A. G. The dynamics in health-related quality of life of patients with stable coronary artery disease were revealed: a network analysis Journal of clinical epidemiology 2019;107:116-123 [PubMed]
  • van den Ende Tom, ter Veer Emil, Machiels M. lanie, Mali Rosa M. A., Abe Nijenhuis Frank A., de Waal Laura, Laarman Marety, Gisbertz Suzanne S., Hulshof Maarten C. C. M., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The efficacy and safety of (Neo)adjuvant therapy for gastric cancer: A network meta-analysis Cancers 2019;11 (1) [PubMed]
  • ter Veer Emil, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The use of (Network) meta-analysis in clinical oncology Frontiers in oncology 2019;9 (AUG) [PubMed]
  • Ngai Lok Lam, ter Veer Emil, van den Boorn H. ctor G., van Herk E. Hugo, van Kleef Jessy Joy, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. TOXview: a novel graphical presentation of cancer treatment toxicity profiles Acta oncologica (Stockholm, Sweden) 2019;58 (8):1138-1148 [PubMed]
  • van Dalen Egbert, Scherer-Rath Michael, van Laarhoven Hanneke, Wiegers Gerard, Hermans Chris Tragedy as Contingency Acknowledgement: Towards a Practical Religious-Scientific Theory Journal of Empirical Theology 2019;32 (2):232-250
  • Henselmans Inge, van Laarhoven Hanneke W.M., de Haes Hanneke C.J.M., Tokat Meltem, Engelhardt Ellen G., van Maarschalkerweerd Pomme E.A., Kunneman Marleen, Ottevanger Petronella B., Dohmen Serge E., Creemers Geert Jan, Sommeijer Dirkje W., de Vos Filip Y.F.L., Smets Ellen M.A. Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial oncologist 2019;24 (2):259-265 [PubMed]
  • de Vos-Geelen Judith, Geurts Sandra Me, van Putten Margreet, Valkenburg-van Iersel Liselot Bj, Grabsch Heike I., Haj Mohammad Nadia, Hoebers Frank Jp, Hoge Chantal V., Jeene Paul M., de Jong Evelien Jm, van Laarhoven Hanneke Wm, Rozema Tom, Slingerland Marije, Tjan-Heijnen Vivianne Cg, Nieuwenhuijzen Grard Ap, Lemmens Valery Epp Trends in treatment and overall survival among patients with proximal esophageal cancer World journal of gastroenterology 2019;25 (47):6835-6846 [PubMed]
  • Sánchez-Querubín Natalia, van Laarhoven Hanneke W M Vlogging at the end of life lancet oncology 2019;20 (7):911-912 [PubMed]

2018

  • Veenstra V. L., Damhofer H., Waasdorp C., van Rijssen L. B., van de Vijver M. J., Dijk F., Wilmink H. W., Besselink M. G., Busch O. R., Chang D. K., Bailey P. J., Biankin A. V., Kocher H. M., Medema J. P., Li J. S., Jiang R., Pierce D. W., van Laarhoven H. W. M., Bijlsma M. F. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy Oncogenesis 2018;7 (11) [PubMed]
  • van Veldhuisen Eran, Vogel Jantien A., Klompmaker Sjors, Busch Olivier R., van Laarhoven Hanneke W. M., van Lienden Krijn P., Wilmink Johanna W., Marsman Hendrik A., Besselink Marc G. Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy HPB: The official journal of the International Hepato Pancreato Biliary Association 2018;20 (7):605-611 [PubMed]
  • de Vries Y. C., Winkels R. M., van den Berg M. M. G. A., de Graaf C., Kelfkens C. S., de Kruif J. Th.C. M., Göker E., Grosfeld S., Sommeijer D. W., van Laarhoven H. W. M., Kampman E., Boesveldt S. Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: A longitudinal comparison with healthy controls FOOD QUALITY AND PREFERENCE 2018;63:135-143
  • Krikken Erwin, Khlebnikov Vitaliy, Zaiss Moritz, Jibodh Rajni A., van Diest Paul J., Luijten Peter R., Klomp Dennis W. J., van Laarhoven Hanneke W. M., Wijnen Jannie P. Amide chemical exchange saturation transfer at 7T: A possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients Breast cancer research 2018;20 (1) [PubMed]
  • Henselmans I., Smets E. M. A., de Haes J. C. J. M., Dijkgraaf M. G. W., de Vos F. Y., van Laarhoven H. W. M. A randomized controlled trial of a skills training for oncologists and a communication aid for patients to stimulate shared decision making about palliative systemic treatment (CHOICE): study protocol BMC cancer 2018;18 (1):55 [PubMed]
  • van Gessel Lidewij D., Abrahams Harriët J. G., Prinsen Hetty, Bleijenberg Gijs, Heins Marianne, Twisk Jos, van Laarhoven Hanneke W. M., Verhagen Stans C. A. H. H. V. M., Gielissen Marieke F. M., Knoop Hans Are the effects of cognitive behavior therapy for severe fatigue in cancer survivors sustained up to 14 years after therapy? Journal of cancer survivorship 2018;12 (4):519-527 [PubMed]
  • Hidding Janine Arm and shoulder function in breast cancer: Impact of medical treatmentBrummen: Hilarius BV; 2018. 160p. ISBN 9789492896803. [UvA Dissertations Online] Radboud University. (Supervisors: Nijhuis-van der Sanden M. W. G., van Laarhoven Hanneke W. M.; Co-supervisors: van der Wees P. J., Beurskens Carien H. G.)
  • Hillen Marij A., Woei-A-Jin F. J. Sherida H., Smets Ellen M. A., van Maarschalkerweerd Pomme E. A., van Laarhoven Hanneke W. M., Sommeijer Dirkje W. Assessment of Challenges Encountered by Dutch Oncologists When Patients Ask for Second Opinions JAMA oncology 2018;4 (10):1425-1426 [PubMed]
  • van Erning Felice N., Mackay Tara M., van der Geest Lydia G. M., Groot Koerkamp B., van Laarhoven Hanneke W. M., Bonsing Bert A., Wilmink Johanna W., van Santvoort Hjalmar C., de Vos-Geelen Judith, van Eijck Casper H. J., Busch Olivier R., Lemmens Valery E., Besselink Marc G. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis Acta oncologica (Stockholm, Sweden) 2018;57 (12):1655-1622 [PubMed]
  • Creemers Aafke, Ebbing Eva A., Pelgrim Thomas C., Lagarde Sjoerd M., van Etten-Jamaludin Faridi S., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M., Krishnadath Kausilia K., Meijer Sybren L., Bijlsma Maarten F., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas Scientific reports 2018;8 (1) [PubMed]
  • Hidding Janine T., Beurskens Carien H. G., van der Wees Philip J., Bos Wilmy C. A. M., Nijhuis-van der Sanden Maria W. G., van Laarhoven Hanneke W. M. Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer Supportive care in cancer 2018;26 (5):1383-1392 [PubMed]
  • van den Ende Tom, Smyth Elizabeth, Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M. Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer Best practice & research. Clinical gastroenterology 2018;36-37:45-52 [PubMed]
  • Cats Annemieke, Jansen Edwin P. M., van Grieken Nicole C. T., Sikorska Karolina, Lind Pehr, Nordsmark Marianne, Meershoek-Klein Kranenbarg Elma, Boot Henk, Trip Anouk K., Swellengrebel H. A. Maurits, van Laarhoven Hanneke W. M., Putter Hein, van Sandick Johanna W., van Berge Henegouwen Mark I., Hartgrink Henk H., van Tinteren Harm, van de Velde Cornelis J. H., Verheij Marcel, van Coevorden Frits, Vanhoutvin Steven, Hulshof Maarten C. CM, Loosveld Olaf J. L., ten Tije A. (Bert) Jan, Erdkamp Frans L. G., Warmerdam Fabienne A. RM, van der Peet Donald L., Verheul Henk M. W., Boerma Djamila, Los Maartje, Slot Annerie, Houtsma Danny, Portielje Johanna E. A., Blaisse Reinoud J. B., Spillenaar Bilgen Ernst Jan, Polée Marco B., Geenen Maud M., Braak Jeffrey P. BM, Neelis Karen J., Slingerland Marije, Jansen Rob L. H., Buijsen Jeroen, Beeker Aart, Eijsbouts Quirijn A. J., van Riel Johanna M. GH, Rozema Tom, van Spronsen Dick Johan, Meerum Terwogt Jetske M., Tanis Bea C., van der Torren-Conze Adelheid M. E., van Hilligersberg Richard Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial lancet oncology 2018;19 (5):616-628
  • ter Veer Emil, Creemers Aafke, de Waal Laura, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis International journal of cancer. Journal international du cancer 2018;143 (2):438-448 [PubMed]
  • Gurney-Champion Oliver J., Klaassen Remy, Froeling Martijn, Barbieri Sebastiano, Stoker Jaap, Engelbrecht Marc R. W., Wilmink Johanna W., Besselink Marc G., Bel Arjan, van Laarhoven Hanneke W. M., Nederveen Aart J. Comparison of six fit algorithms for the intravoxel incoherent motion model of diffusionweighted magnetic resonance imaging data of pancreatic cancer patients PLoS ONE 2018;13 (4) [PubMed]
  • ter Veer Emil, van Rijssen L. Bengt, Besselink Marc G., Mali Rosa M. A., Berlin Jordan D., Boeck Stefan, Bonnetain Franck, Chau Ian, Conroy Thierry, van Cutsem Eric, Deplanque Gael, Friess Helmut, Glimelius Bengt, Goldstein David, Herrmann Richard, Labianca Roberto, van Laethem Jean-Luc, Macarulla Teresa, van der Meer Jonathan H. M., Neoptolemos John P., Okusaka Takuji, O'Reilly Eileen M., Pelzer Uwe, Philip Philip A., van der Poel Marcel J., Reni Michele, Scheithauer Werner, Siveke Jens T., Verslype Chris, Busch Olivier R., Wilmink Johanna W., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease lancet oncology 2018;19 (3):e151-e160
  • ter Veer Emil, van den Ende Tom, Creemers Aafke, de Waal Laura, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysis Acta oncologica (Stockholm, Sweden) 2018;57 (12):1599-1604 [PubMed]
  • Slagter Astrid E, Jansen Edwin P M, van Laarhoven Hanneke W M, van Sandick Johanna W, van Grieken Nicole C T, Sikorska Karolina, Cats Annemieke, Muller-Timmermans Pietje, Hulshof Maarten C C M, Boot Henk, Los Maartje, Beerepoot Laurens V, Peters Frank P J, Hospers Geke A P, van Etten Boudewijn, Hartgrink Henk H, van Berge Henegouwen Mark I, Nieuwenhuijzen Grard A P, van Hillegersberg Richard, van der Peet Donald L, Grabsch Heike I, Verheij Marcel CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer BMC cancer 2018;18 (1):877 [PubMed]
  • Noordman Bo Jan, Spaander Manon C. W., Valkema Roelf, Wijnhoven Bas P. L., van Berge Henegouwen Mark I., Shapiro Joël, Biermann Katharina, van der Gaast Ate, van Hillegersberg Richard, Hulshof Maarten C. C. M., Krishnadath Kausilia K., Lagarde Sjoerd M., Nieuwenhuijzen Grard A. P., Oostenbrug Liekele E., Siersema Peter D., Schoon Erik J., Sosef Meindert N., Steyerberg Ewout W., van Lanschot J. Jan B., Doukas Michael, Krak Nanda C., Poley Jan-Werner, van Rij Caroline M., Bergman Jaques J. GH. M., Gisbertz Suzanne S., van Laarhoven Hanneke W. M., Meijer Sybren L., Goense Lucas, Haj Mohammad Nadia, Hobbelink Monique G. G., Offerhaus G. Johan A., Vleggaar Frank, Curvers Wouter L., Creemers Geert-Jan, Roef Mark J., van der Sangen Maurice J. C., Buijsen Jeroen, Riedl Robert G., Schreurs Wendy M. J., Warmerdam Fabienne A. RM, Janssen M. J. R., van der Post Chella, Radema Sandra A., Rosman Camiel, Rütten Heidi Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study lancet oncology 2018;19 (7):965-974
  • Noordman Bo Jan, Verdam Mathilde G. E., Lagarde Sjoerd M., Hulshof Maarten C. C. M., van Hagen Pieter, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R., ten Kate Fiebo J. W., Creemers Geert-Jan M., Punt Cornelis J. A., Plukker John Th M., Verheul Henk M. W., Spillenaar Bilgen Ernst J., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., Steyerberg Ewout W., van der Gaast Ate, Sprangers Mirjam A. G., van Lanschot J. Jan B. Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial Journal of clinical oncology 2018;36 (3):268-+ [PubMed]
  • Brenkman H. J. F., Gertsen E. C., Vegt E., van Hillegersberg R., van Berge Henegouwen M. I., Gisbertz S. S., Luyer M. D. P., Nieuwenhuijzen G. A. P., van Lanschot J. J. B., Lagarde S. M., de Steur W. O., Hartgrink H. H., Stoot J. H. M. B., Hulsewe K. W. E., Spillenaar Bilgen E. J., van Det M. J., Kouwenhoven E. A., van der Peet D. L., Daams F., van Sandick J. W., van Grieken N. C. T., Heisterkamp J., van Etten B., Haveman J. W., Pierie J. P., Jonker F., Thijssen A. Y., Belt E. J. T., van Duijvendijk P., Wassenaar E., van Laarhoven H. W. M., Wessels F. J., Haj Mohammad N., van Stel H. F., Frederix G. W. J., Siersema P. D., Ruurda J. P. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: A multicenter prospective study (PLASTIC-study) BMC cancer 2018;18 (1) [PubMed]
  • Klaassen Remy, Gurney-Champion Oliver J., Engelbrecht Marc R. W., Stoker Jaap, Wilmink Johanna W., Besselink Marc G., Bel Arjan, van Tienhoven Geertjan, van Laarhoven Hanneke W. M., Nederveen Aart J. Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients International journal of radiation oncology, biology, physics 2018;102 (4):1052-1062 [PubMed]
  • Veenstra Veronique L., Garcia-Garijo Andrea, van Laarhoven Hanneke W., Bijlsma Maarten F. Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer Cancers 2018;10 (2):E34 [PubMed]
  • Klaassen Remy, Larue Ruben T. H. M., Mearadji Banafsche, van der Woude Stephanie O., Stoker Jaap, Lambin Philippe, van Laarhoven Hanneke W. M. Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients PLoS ONE 2018;13 (11) [PubMed]
  • Jelvehgaran Pouya, Alderliesten Tanja, Georgiou Giota, Meijer Sybren L., Bloemen Paul R., Kodach Liudmila L., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M., Rasch Coen R. N., van Leeuwen Ton G., de Boer Johannes F., de Bruin Martijn, van Herk Marcel Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: An ex vivo study Biomedical optics express 2018;9 (9):4196-4216 [PubMed]
  • Visser Annemiek, Prins Judith B., Jansen Lisette, Radema Sandra A., Schlooz Margrethe S., van Dalen Thijs, van Laarhoven Hanneke W. M. Group medical consultations (GMCs) and tablet-based online support group sessions in the follow-up of breast cancer: A multicenter randomized controlled trial Breast (Edinburgh, Scotland) 2018;40:181-188 [PubMed]
  • van Putten Margreet, Koëter Marijn, van Laarhoven Hanneke W. M., Lemmens Valery E. P. P., Siersema Peter D., Hulshof Maarten C. C. M., Verhoeven Rob H. A., Nieuwenhuijzen Grard A. P. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer Annals of surgery 2018;267 (2):303-310 [PubMed]
  • Khurshed Mohammed, Aarnoudse Niels, Hulsbos Renske, Hira Vashendriya V. V., van Laarhoven Hanneke W. M., Wilmink Johanna W., Molenaar Remco J., van Noorden Cornelis J. F. IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity FASEB journal 2018;32 (11):6344-6352 [PubMed]
  • ter Veer Emil, Prinsen Hetty, Sprangers Mirjam A. G., Zwinderman Koos A. H., Bleijenberg Gijs, van der Pouw Kraan Tineke C. T. M., de Vries I. Jolanda M., Wierenga Eddy A., van Laarhoven Hanneke W. M. Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial Cancer investigation 2018;36 (7):371-377 [PubMed]
  • Lagarde Sjoerd M., Anderegg Martinus C. J., Gisbertz Suzanne S., Meijer Sybren L., Hulshof Maarten C. C. M., Bergman Jacques J. G. H. M., van Laarhoven Hanneke W. M., Henegouwen Mark I. van Berge Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery Journal of thoracic disease 2018;10 (3):1511-1521 [PubMed]
  • Takeuchi M., van Laarhoven H. W. M., Fang X., Pfeiffer P., Ajani J. A. Meta-enrichment analysis to identify a higher response patient population to S-1/cisplatin for advanced gastric cancer Annals of oncology 2018;29:viii655 [PubMed]
  • Mari Luigi, Hoefnagel Sanne J. M., Zito Domenico, van de Meent Marian, van Endert Peter, Calpe Silvia, Sancho Serra Maria del Carmen, Heemskerk Mirjam H. M., van Laarhoven Hanneke W. M., Hulshof Maarten C. C. M., Gisbertz Susanne S., Medema Jan Paul, van Berge Henegouwen Mark I., Meijer Sybren L., Bergman Jacques J. G. H. M., Milano Francesca, Krishnadath Kausilia K. microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients Gastroenterology 2018;155 (3):784-798 [PubMed]
  • Veenstra Veronique L. Molecular understanding of Hedgehog-dependent cancers: From pathways to patients 2018. 245p. ISBN 9789463800686. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven H. W. M. , Medema J. P.; Co-supervisor: Bijlsma M. F.)
  • Hillen Marij A., Smets Ellen M. A., Onderwater Astrid, van Laarhoven Hanneke W. M., Sommeijer Dirkje W. Motivaties en ervaringen van patiënten met ongeneeslijke kanker Nederlands tijdschrift voor geneeskunde 2018;162 (34)
  • le Large Tessa Ya Sung, el Hassouni Btissame, Kazemier Geert, Piersma Sander R., van Laarhoven Hanneke W. M., Bijlsma Maarten F., Jimenez Cornelia R., Giovannetti Elisa Multidrug-resistant transporter expression does not always result in drug resistance Cancer science 2018;109 (10):3360-3362 [PubMed]
  • Muishout George, van Laarhoven Hanneke W. M., Wiegers Gerard, Popp-Baier Ulrike Muslim physicians and palliative care: attitudes towards the use of palliative sedation Supportive care in cancer 2018;26 (11):3701-3710 [PubMed]
  • Coebergh van den Braak R. R. J., van Rijssen L. B., van Kleef J. J., Vink G. R., Berbee M., van Berge Henegouwen M. I., Bloemendal H. J., Bruno M. J., Burgmans M. C., Busch O. R. C., Coene P. P. L. O., Coupé V. M. H., Dekker J. W. T., van Eijck C. H. J., Elferink M. A. G., Erdkamp F. L. G., van Grevenstein W. M. U., de Groot J. W. B., van Grieken N. C. T., de Hingh I. H. J. T., Hulshof M. C. C. M., Ijzermans J. N. M., Kwakkenbos L., Lemmens V. E. P. P., Los M., Meijer G. A., Molenaar I. Q., Nieuwenhuijzen G. A. P., de Noo M. E., van de Poll-Franse L. V., Punt C. J. A., Rietbroek R. C., Roeloffzen W. W. H., Rozema T., Ruurda J. P., van Sandick J. W., Schiphorst A. H. W., Schipper H., Siersema P. D., Slingerland M., Sommeijer D. W., Spaander M. C. W., Sprangers M. A. G., Stockmann H. B. A. C., Strijker M., van Tienhoven G., Timmermans L. M., Tjin-A-Ton M. L. R., van der Velden A. M. T., Verhaar M. J., Verkooijen H. M., Vles W. J., de Vos-Geelen J. M. P. G. M., Wilmink J. W., Zimmerman D. D. E., van Oijen M. G. H., Koopman M., Besselink M. G. H., van Laarhoven H. W. M. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative Acta oncologica (Stockholm, Sweden) 2018;57 (2):195-202 [PubMed]
  • Anderegg Maarten C. J. Optimization of treatment strategies and prognostication for patients with esophageal cancer 2018. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Berge Henegouwen M. I., Busch O. R. C.; Co-supervisors: Gisbertz S., van Laarhoven H. W. M.)
  • Veenstra Veronique L., Dingjan Ilse, Waasdorp Cynthia, Damhofer Helene, van der Wal Allard C., van Laarhoven Hanneke W., Medema Jan Paul, Bijlsma Maarten F. Patched-2 functions to limit Patched-1 deficient skin cancer growth Cellular oncology 2018;41 (4):427-437 [PubMed]
  • Zijlstra Myrte, van der Geest Lydia G. M., van Laarhoven Hanneke W. M., Lemmens Valery E. P. P., van de Poll-Franse Lonneke V., Raijmakers Natasja J. H. Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands Acta oncologica (Stockholm, Sweden) 2018;57 (9):1185-1191 [PubMed]
  • van den Boorn H. G., Engelhardt E. G., van Kleef J., Sprangers M. A. G., van Oijen M. G. H., Abu-Hanna A., Zwinderman A. H., Coupé V. M. H., van Laarhoven H. W. M. Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis PLoS ONE 2018;13 (2):e0192310 [PubMed]
  • Borggreve A. S., Mook S., Verheij M., Mul V. E. M., Bergman J. J., Bartels-Rutten A., ter Beek L. C., Beets-Tan R. G. H., Bennink R. J., van Berge Henegouwen M. I., Brosens L. A. A., Defize I. L., van Dieren J. M., Dijkstra H., van Hillegersberg R., Hulshof M. C., van Laarhoven H. W. M., Lam M. G. E. H., van Lier A. L. H. M. W., Muijs C. T., Nagengast W. B., Nederveen A. J., Noordzij W., Plukker J. T. M., van Rossum P. S. N., Ruurda J. P., van Sandick J. W., Weusten B. L. A. M., Voncken F. E. M., Yakar D., Meijer G. J., Aleman B. M. P., Borra R. J. H., van Etten B., Gisbertz S. S., Goense L., Haj Mohammad N., Hartemink K. J., Kappert P., Kats-Ugurlu G., Kodach L. L., Korteweg T., Krishnadath K. K., Langendijk J. A., de Leng W. W. J., Meijer S. L., Potze J. H., Stoker J., Vegt E., Verkooijen H. M., Vollenbrock S. E., Wessels F. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study BMC cancer 2018;18 (1) [PubMed]
  • Larue Ruben T. H. M., Klaassen Remy, Jochems Arthur, Leijenaar Ralph T. H., Hulshof Maarten C. C. M., van Berge Henegouwen Mark I., Schreurs Wendy M. J., Sosef Meindert N., van Elmpt Wouter, van Laarhoven Hanneke W. M., Lambin Philippe Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer Acta oncologica (Stockholm, Sweden) 2018;57 (11):1475-1481 [PubMed]
  • ter Veer Emil, van Kleef Jessy Joy, Schokker Sandor, van der Woude Stephanie O., Laarman Marety, Haj Mohammad Nadia, Sprangers Mirjam A. G., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis European journal of cancer (Oxford, England 2018;103:214-226 [PubMed]
  • van Kleef J. J., van de Poll-Franse L. V., Verhoeven R. H., Slingerland M., Ruurda J. P., Heisterkamp J., Rosman C., de Groot J. W. B., Kouwenhoven E. A., van Dijk M. A., de Graaf E., van Voorthuizen T., Daams F., Lagarde S., Nieuwenhuijzen G. A. P., Vincent J., van Berge Henegouwen M., van Oijen M. G. H., Sprangers M. A. G., van Laarhoven H. W. M. Prospective observational cohort study of oesophagogastric cancer patients (POCOP): A Dutch nationwide cohort Annals of oncology 2018;29:viii234 [PubMed]
  • Kruizinga Renske, Jafari Najmeh, Scherer-Rath Michael, Schilderman Hans, Bires Jennifer, Puchalski Christina, van Laarhoven Hanneke Relating to the experience of contingency in patients with advanced cancer; an interview study in American patients Journal of pain and symptom management 2018;55 (3):913-921 [PubMed]
  • Klaassen Remy, Gurney-Champion Oliver J., Wilmink Johanna W., Besselink Marc G., Engelbrecht Marc R. W., Stoker Jaap, Nederveen Aart J., van Laarhoven Hanneke W. M. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma Magnetic resonance imaging 2018;50:1-9 [PubMed]
  • ter Veer Emil, van Kleef Jessy Joy, Sprangers Mirjam A. G., Haj Mohammad Nadia, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review Gastric cancer 2018;21 (2):183-195 [PubMed]
  • Hidding Janine, van Laarhoven Hanneke Response to letter to the editor Supportive care in cancer 2018;26 (6):1689 [PubMed]
  • Henselmans Inge, van Laarhoven Hanneke Roosmaryn pilgram and francisca snoeck Henkemans. A pragma-dialectical perspective on obstacles to shared decision-making https://doi.org/10.1075/jaic.18027.pil Journal of Argumentation in Context 2018;7 (2):177-180
  • Maracle Chrissta X., Jeucken Kim C. M., Helder Boy, Gulik Thomas M. van, Steins Anne, Laarhoven Hanneke W. M. van, Tas Sander W. Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis Oncotarget 2018;9 (47):28445-28455 [PubMed]
  • de Vries Y. C., Boesveldt S., Kelfkens C. S., Posthuma E. E., van den Berg M. M. G. A., de Kruif J. Th C. M., Haringhuizen A., Sommeijer D. W., Buist N., Grosfeld S., de Graaf C., van Laarhoven H. W. M., Kampman E., Winkels R. M. Taste and smell perception and quality of life during and after systemic therapy for breast cancer Breast cancer research and treatment 2018;170 (1):27-34 [PubMed]
  • van der Horst Astrid, Versteijne Eva, Besselink Marc G. H., Daams Joost G., Bulle Esther B., Bijlsma Maarten F., Wilmink Johanna W., van Delden Otto M., van Hooft Jeanin E., Franken Nicolaas A. P., van Laarhoven Hanneke W. M., Crezee Johannes, van Tienhoven Geertjan The clinical benefit of hyperthermia in pancreatic cancer: a systematic review International journal of hyperthermia 2018;34 (7):969-979 [PubMed]
  • Strijker Marin, Gerritsen Arja, van Hilst Jony, Bijlsma Maarten F., Bonsing Bert A., Brosens Lodewijk A., Bruno Marco J., van Dam Ronald M., Dijk Frederike, van Eijck Casper H., Farina Sarasqueta Arantza, Fockens Paul, Gerhards Michael F., Groot Koerkamp Bas, van der Harst Erwin, de Hingh Ignace H., van Hooft Jeanin E., Huysentruyt Clément J., Kazemier Geert, Klaase Joost M., van Laarhoven Cornelis J., van Laarhoven Hanneke W., Liem Mike S., de Meijer Vincent E., van Rijssen L. Bengt, van Santvoort Hjalmar C., Suker Mustafa, Verhagen Judith H., Verheij Joanne, Verspaget Hein W., Wennink Roos A., Wilmink Johanna W., Molenaar I. Quintus, Boermeester Marja A., Busch Olivier R., Besselink Marc G. The Dutch Pancreas Biobank within the Parelsnoer Institute: A nationwide Biobank of pancreatic and periampullary diseases Pancreas 2018;47 (4):495-501 [PubMed]
  • Creemers Aafke, Ebbing Eva A., Hooijer Gerrit K. J., Stap Lisanne, Jibodh-Mulder Rajni A., Gisbertz Susanne S., Henegouwen Mark I. van Berge, van Montfoort Maurits L., Hulshof Maarten C. C. M., Krishnadath Kausilia K., van Oijen Martijn G. H., Bijlsma Maarten F., Meijer Sybren L., van Laarhoven Hanneke W. M. The dynamics of HER2 status in esophageal adenocarcinoma Oncotarget 2018;9 (42):26787-26799 [PubMed]
  • van den Ende T., ter Veer E., Machiels M., Mali R. M. A., Abe Nijenhuis F. A., Waal L. D., Laarman M., Gisbertz S. S., Hulshof M. C. C. M., van Oijen M. G. H., van Laarhoven H. W. M. The efficacy and safety of (neo)adjuvant therapy for gastric cancer: A network meta-analysis Annals of oncology 2018;29:viii227 [PubMed]
  • Jeene Paul M., van Laarhoven Hanneke W. M., Hulshof Maarten C. C. M. The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer Best practice & research. Clinical gastroenterology 2018;36-37:53-59 [PubMed]
  • Steins Anne, Bijlsma Maarten F., van Laarhoven Hanneke W. M. The role of the tumor microenvironment in pancreatic ductal adenocarcinoma and preclinical models to study itin: Conn's Handbook of Models for Human Aging. Elsevier; 2018. p. 735-748
  • Akkermans Aranka, Henkemans Francisca Snoeck, Labrie Nanon, Henselmans Inge, van Laarhoven Hanneke The stereotypicality of symptomatic and pragmatic argumentation in consultations about palliative systemic treatment for advanced cancer Journal of Argumentation in Context 2018;7 (2):181-203
  • Kruizinga R., Scherer-Rath M., Schilderman J. B. A. M., Puchalski C. M., van Laarhoven H. W. M. Towards a fully-fledged integration of spiritual care and medical care Journal of pain and symptom management 2018;55 (3):1035-1040 [PubMed]
  • van Laarhoven H. W. M., Henselmans I., van Maarschalkerweerd P., de Haes H., Sommeijer D. W., Ottevanger P. B., Fiebrich H. B., Dohmen S. E., Creemers G. J. M., de Vos F. Y. F. L., Smets E. M. Training oncologists and preparing patients for shared decision making about palliative systemic treatment: Results from the randomized controlled CHOICE study Annals of oncology 2018;29:viii548 [PubMed]
  • Schroten-Loef C., Verhoeven R. H. A., de Hingh I. H. J. T., van de Wouw A. J., van Laarhoven H. W. M., Lemmens V. E. P. P. Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012 European journal of cancer (Oxford, England 2018;101:77-86 [PubMed]
  • Slagter A. E., Sikorska K., Grootscholten C., van Laarhoven H. W. M., Boot H., Meershoek-Klein Kranenbarg E., van de Velde C. J. H., van Grieken N. C., Jansen E. P. M., Verheij M., Cats A. Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial Annals of oncology 2018;29:viii233 [PubMed]
  • Ebbing Eva A. What tumor cells cannot resist: Mechanisms of therapy resistance in esophageal adenocarcinoma 2018. ISBN 9789462958739. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven H. W. M., Medema J. P.; Co-supervisors: Bijlsma M. F., Punt C. J. A.)
  • Wind Jan, Nugteren Ineke C., van Laarhoven Hanneke W. M., van Weert Henk C. P. M., Henselmans Inge Who should provide care for patients receiving palliative chemotherapy? A qualitative study among Dutch general practitioners and oncologists Scandinavian journal of primary health care 2018;36 (4):437-445 [PubMed]
  • van Putten M., Verhoeven R. H. A., Koëter M., van Laarhoven H. W. M., van Sandick J. W., Plukker J. T. M., Siersema P. D., Hulshof M. C. C. M., Wijnhoven B. P. L., Lemmens V. E. P. P., Nieuwenhuijzen G. A. P. Ziekenhuis van diagnose beïnvloedt kans op curatieve behandeling voor slokdarm- en maagkanker Nederlands tijdschrift voor geneeskunde 2018;162:D1970 [PubMed]
  • van Putten Margreet, Verhoeven Rob H. A., Koëter Marijn, van Laarhoven Hanneke W. M., van Sandick Johanna W., Plukker John T. M., Siersema Peter D., Hulshof Maarten C. C. M., Wijnhoven Bas P. L., Lemmens Valery E. P. P., Nieuwenhuijzen Grard A. P. Ziekenhuis van diagnose beïnvloedt kans op curatieve behandeling voor slokdarm- en maagkanker: Een pleidooi voor regionaal tumorspecifiek multidisciplinair overleg Nederlands tijdschrift voor geneeskunde 2018;62 (12)

2017

  • Keikes L., Klümpen H., van Laarhoven H. W. M. A 52-year-old oncology patient with acute severe abdominal pain Netherlands journal of medicine 2017;75 (8):359-360 [PubMed]
  • Gurney-Champion Oliver J., Versteijne Eva, van der Horst Astrid, Lens Eelco, Rütten Heidi, Heerkens Hanne D., Paardekooper Gabriel M. R. M., Berbee Maaike, Rasch Coen R. N., Stoker Jaap, Engelbrecht Marc R. W., van Herk Marcel, Nederveen Aart J., Klaassen Remy, van Laarhoven Hanneke W. M., van Tienhoven Geertjan, Bel Arjan Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study Acta oncologica (Stockholm, Sweden) 2017;56 (7):923-930 [PubMed]
  • Ho V. K. Y., Jansen E. P. M., Wijnhoven B. P. L., Neelis K. J., van Sandick J. W., Verhoeven R. H. A., Lemmens V. E. P., van Laarhoven H. W. M. Adjuvant Chemoradiotherapy for Non-Pretreated Gastric Cancer Annals of surgical oncology 2017;24 (12):3647-3657 [PubMed]
  • ter Veer Emil, Ngai Lok Lam, van Valkenhoef Gert, Haj Mohammad Nadia, Anderegg Maarten C. J., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis Scientific reports 2017;7 (1):7142 [PubMed]
  • Linnekamp J. F., Butter R., Spijker R., Medema J. P., van Laarhoven H. W. M. Clinical and biological effects of demethylating agents on solid tumours - A systematic review Cancer treatment reviews 2017;54:10-23 [PubMed]
  • Creemers A., Krausz S., Strijker M., van der Wel M. J., Soer E. C., Reinten R. J., Besselink M. G., Wilmink J. W., van de Vijver M. J., van Noesel C. J. M., Verheij J., Meijer S. L., Dijk F., Bijlsma M. F., van Oijen M. G. H., van Laarhoven H. W. M. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS 2017;1868 (2):394-403 [PubMed]
  • Jeene P. M., Versteijne E., van Berge Henegouwen M. I., Bergmann J. J. G. H. M., Geijsen E. D., Muller K., van Laarhoven H. W. M., Hulshof M. C. C. M. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment Diseases of the esophagus 2017;30 (2):1-5 [PubMed]
  • de Vries Y. C., van den Berg M. M. G. A., de Vries J. H. M., Boesveldt S., de Kruif J. Th C. M., Buist N., Haringhuizen A., Los M., Sommeijer D. W., Timmer-Bonte J. H. N., van Laarhoven H. W. M., Visser M., Kampman E., Winkels R. M. Differences in dietary intake during chemotherapy in breast cancer patients compared to women without cancer Supportive care in cancer 2017;25 (8):2581-2591 [PubMed]
  • Hato Stanleyson V., Figdor Carl G., Takahashi Susumu, Pen Anja E., Halilovic Altuna, Bol Kalijn F., Vasaturo Angela, Inoue Yukie, de Haas Nienke, Verweij Dagmar, van Herpen Carla M. L., Kaanders Johannes H., van Krieken Johan H. J. M., van Laarhoven Hanneke W. M., Hooijer Gerrit K. J., Punt Cornelis J. A., Asai Akira, de Vries I. Jolanda M., Joost Lesterhuis W. Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity Oncotarget 2017;8 (33):54434-54443 [PubMed]
  • Creemers A., ter Veer E., de Waal L., Lodder P., Hooijer G. K. J., van Grieken N. C. T., Bijlsma M. F., Meijer S. L., van Oijen M. G. H., van Laarhoven H. W. M. Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis Scientific reports 2017;7 (1):3135 [PubMed]
  • Ebbing Eva A., Steins Anne, Fessler Evelyn, Stathi Phylicia, Lesterhuis Willem Joost, Krishnadath Kausilia K., Vermeulen Louis, Medema Jan Paul, Bijlsma Maarten F., van Laarhoven Hanneke W. M. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition Gastroenterology 2017;153 (1):63-76.e14 [PubMed]
  • de Vries Yfke C. Everything tastes different: The impact of changes in chemosensory perception on food preferences, food intake and quality of life during chemotherapy in cancer patientsWageningen: Wageningen Academic Publishers; 2017. 170p. ISBN 9789463436090. [UvA Dissertations Online] Wageningen University. (Supervisors: de Graaf C., van Laarhoven H. W. M.; Co-supervisors: Winkels R. M., Boesveldt S.)
  • Henselmans I., Kunneman M., van Laarhoven H. W. M. Gedeelde besluitvorming voor goede zorg Nederlands tijdschrift voor geneeskunde 2017;161:D947 [PubMed]
  • Henselmans I., Smets E. M. A., Han P. K. J., de Haes H. C. J. C., Laarhoven H. W. M. van How long do I have? Observational study on communication about life expectancy with advanced cancer patients Patient education and counseling 2017;100 (10):1820-1827 [PubMed]
  • Kruizinga Renske, Scherer-Rath Michael, Schilderman Johannes B. A. M., Weterman Mariëtte, Young Teresa, van Laarhoven Hanneke W. M. Images of God and attitudes towards death in relation to spiritual wellbeing: an exploratory side study of the EORTC QLQ-SWB32 validation study in palliative cancer patients BMC palliative care 2017;16 (1):67 [PubMed]
  • Vogel Jantien A., Rombouts Steffi J., de Rooij Thijs, van Delden Otto M., Dijkgraaf Marcel G., van Gulik Thomas M., van Hooft Jeanin E., van Laarhoven Hanneke W., Martin Robert C., Schoorlemmer Annuska, Wilmink Johanna W., van Lienden Krijn P., Busch Olivier R., Besselink Marc G. Induction Chemotherapy Followed by Resection or Irreversible Electroporation in Locally Advanced Pancreatic Cancer (IMPALA): A Prospective Cohort Study Annals of surgical oncology 2017;24 (9):2734-2743 [PubMed]
  • Le Large T. Y. S., Bijlsma M. F., Kazemier G., van Laarhoven H. W. M., Giovannetti E., Jimenez C. R. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies Seminars in cancer biology 2017;44:153-169 [PubMed]
  • Bisseling Else M., Schellekens Melanie P. J., Jansen Ellen T. M., van Laarhoven Hanneke W. M., Prins Judith B., Speckens Anne E. M. Mindfulness-based stress reduction for breast cancer patients: a mixed method study on what patients experience as a suitable stage to participate Supportive care in cancer 2017;25 (10):3067-3074 [PubMed]
  • Kruizinga Renske, Hartog Iris D., Scherer-Rath Michael, Schilderman Hans, van Laarhoven Hanneke Modes of relating to contingency: An exploration of experiences in advanced cancer patients Palliative & supportive care 2017;15 (4):444-453 [PubMed]
  • Kruizinga Renske, Hartog Iris D., Scherer-Rath Michael, Schilderman Hans, van Laarhoven Hanneke Modes of relating to contingency: An exploration of experiences in advanced cancer patients : Erratum Palliative & supportive care 2017;15 (4):755 [PubMed]
  • van der Velden D. L., van Herpen C. M. L., van Laarhoven H. W. M., Smit E. F., Groen H. J. M., Willems S. M., Nederlof P. M., Langenberg M. H. G., Cuppen E., Sleijfer S., Steeghs N., Voest E. E. Molecular Tumor Boards: current practice and future needs Annals of oncology 2017;28 (12):3070-3075 [PubMed]
  • ter Voert Edwin G. W. Multimodal and multiparametric imaging in colorectal liver metastasis 2017. 226p. ISBN 9789462957145. [UvA Dissertations Online] Radboud Universiteit: Radiology & Nuclear Medicine. (Supervisors: Heerschap A., van Laarhoven H. W. M., Oyen W. J. G.; Co-supervisor: de Geus-Oei L. F.)
  • van der Geest Lydia G. M., Haj Mohammad Nadia, Besselink Marc G. H., Lemmens Valery E. P. P., Portielje Johanneke E. A., van Laarhoven Hanneke W. M., Wilmink J. Hanneke W. Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer Cancer medicine 2017;6 (12):2840-2849 [PubMed]
  • van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M. Neoadjuvant chemotherapy in oesophageal adenocarcinoma lancet oncology 2017;18 (11):e639
  • van Laarhoven Hanneke W. M., Pijnenburg Lisa J., Hulshof Maarten C. C. M. On the Receiving End of Autonomy and Law oncologist 2017;22 (9):1143-1145 [PubMed]
  • Kruizinga Renske Out of the blue: Experiences of contingency in advanced cancer patients 2017. 149p. ISBN 9789462995697. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven H. W. M., Schilderman J. B. A. M.; Co-supervisor: Scherer-Rath M.)
  • van Putten Margreet, Lemmens Valery, van Laarhoven Hanneke, Pruijt Hans, Nieuwenhuijzen Grard, Verhoeven Rob Poor compliance with perioperative treatment in patients with resectable gastric cancer Annals of oncology 2017;28:iii17
  • Anderegg M. C. J., van der Sluis P. C., Ruurda J. P., Gisbertz S. S., Hulshof M. C. C. M., van Vulpen M., Mohammed N. Haj, van Laarhoven H. W. M., Wiezer M. J., Los M., van Berge Henegouwen M. I., van Hillegersberg R. Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma Annals of surgical oncology 2017;24 (8):2282-2290 [PubMed]
  • Henselmans Inge, van Laarhoven Hanneke W. M., van der Vloodt Jane, de Haes Hanneke C. J. M., Smets Ellen M. A. Shared decision making about palliative chemotherapy: A qualitative observation of talk about patients' preferences Palliative medicine 2017;31 (7):625-633 [PubMed]
  • Groot Marieke, Ebenau Anne F., Koning Helen, Visser Anja, Leget Carlo, van Laarhoven Hanneke W. M., van Leeuwen René, Ruben Riet, Wulp Marijke, Garssen Bert Spiritual care by nurses in curative cancer care: Protocol for a national, multicentre, mixed method study Journal of advanced nursing 2017;73 (9):2201-2207 [PubMed]
  • Veenstra Veronique L., Damhofer Helene, Waasdorp Cynthia, Steins Anne, Kocher Hemant M., Medema Jan P., van Laarhoven Hanneke W., Bijlsma Maarten F. Stromal SPOCK1 supports invasive pancreatic cancer growth Molecular oncology 2017;11 (8):1050-1064 [PubMed]
  • Molenaar Remco J., Coelen Robert J. S., Khurshed Mohammed, Roos Eva, Caan Matthan W. A., van Linde Myra E., Kouwenhoven Mathilde, Bramer Jos A. M., Bovée Judith V. M. G., Mathôt Ron A., Klümpen Heinz-Josef, van Laarhoven Hanneke W. M., van Noorden Cornelis J. F., Vandertop W. Peter, Gelderblom Hans, van Gulik Thomas M., Wilmink Johanna W. Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours BMJ open 2017;7 (6):e014961 [PubMed]
  • Jeene Paul M., Versteijne Eva, van Berge Henegouwen Mark I., Bergmann Jacques J. G. H. M., Geijsen Elisabeth D., van Laarhoven Hanneke W. M., Hulshof Maarten C. C. M. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation Acta oncologica (Stockholm, Sweden) 2017;56 (1):33-38 [PubMed]
  • Steins Anne, Ebbing Eva A., Pistorius Marcel C. M., Waasdorp Cynthia, Krishnadath Kausilia K., Medema Jan Paul, Wilmink Johanna W., Mathôt Ron A. A., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel Drug delivery 2017;24 (1):1801-1810 [PubMed]
  • Worm-Smeitink M., Gielissen M., Bloot L., van Laarhoven H. W. M., van Engelen B. G. M., van Riel P., Bleijenberg G., Nikolaus S., Knoop H. The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength Journal of psychosomatic research 2017;98:40-46 [PubMed]
  • Vivat B., Young T. E., Winstanley J., Arraras J. I., Black K., Boyle F., Bredart A., Costantini A., Guo J., Irarrazaval M. E., Kobayashi K., Kruizinga R., Navarro M., Omidvari S., Rohde G. E., Serpentini S., Spry N., van Laarhoven H. W. M., Yang G. M. The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancer European journal of cancer care 2017;26 (6):e12697 [PubMed]
  • Butter R., Lagarde S. M., van Oijen M. G. H., Anderegg M. C. J., Gisbertz S. S., Meijer S. L., Hulshof M. C. C. M., Bergman J. J. G. H. M., van Berge Henegouwen M. I., van Laarhoven H. W. M. Treatment strategies in recurrent esophageal or junctional cancer Diseases of the esophagus 2017;30 (9):1-9 [PubMed]
  • Haj Mohammad N., Bernards N., van Putten M., Lemmens V. E. P. P., van Oijen M. G. H., van Laarhoven H. W. M. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer European journal of cancer (Oxford, England 2017;78:28-36 [PubMed]
  • van den Berg M. M. G. A., Winkels R. M., de Kruif J. Th C. M., van Laarhoven H. W. M., Visser M., de Vries J. H. M., de Vries Y. C., Kampman E. Weight change during chemotherapy in breast cancer patients: a meta-analysis BMC cancer 2017;17 (1):259 [PubMed]

2016

  • Haj Mohammad Nadia, de Rooij Sophia, Hulshof Maarten, Ruurda Jelle, Wijnhoven Bas, Erdkamp Frans, Sosef Meindert, Gisbertz Suzanne, van Berge Henegouwen Mark, Sprangers Mirjam, van Laarhoven Hanneke Activities of daily living and quality of life during treatment with neoadjuvant chemoradiotherapy and after surgery in patients with esophageal cancer Journal of surgical oncology 2016;114 (6):684-690 [PubMed]
  • van der Woude Stephanie O., van Laarhoven Hanneke W. M. Acute hypertension during ramucirumab infusion in two patients with advanced oesophagogastric cancer BMJ case reports 2016;2016 [PubMed]
  • Ebbing Eva A., Medema Jan Paul, Damhofer Helene, Meijer Sybren L., Krishnadath Kausilia K., van Berge Henegouwen Mark I., Bijlsma Maarten F., van Laarhoven Hanneke W. M. ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3 Oncotarget 2016;7 (9):10243-10254 [PubMed]
  • Schellekens Melanie P. J., Jansen Ellen T. M., Willemse Heidi H. M. A., van Laarhoven Hanneke W. M., Prins Judith B., Speckens Anne E. M. A qualitative study on mindfulness-based stress reduction for breast cancer patients: how women experience participating with fellow patients Supportive care in cancer 2016;24 (4):1813-1820 [PubMed]
  • Bulten Ben F. Biomarkers for the early detection of cancer treatment induced cardiotoxicityEnschede: 2016. 183p. ISBN 9789036541947. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Geus-Oei L. F., van Laarhoven H. W. M.; Co-supervisor: Oyen W. O.)
  • Visser Annemiek, van de Ven Eline M. W., Ruczynski Larissa I. A., Blaisse Reinoud J. B., van Halteren Henk K., Aben Katja, van Laarhoven Hanneke W. M. Cardiac monitoring during adjuvant trastuzumab therapy: Guideline adherence in clinical practice Acta oncologica (Stockholm, Sweden) 2016;55 (4):423-429 [PubMed]
  • Hulshof M. C. C. M., van Laarhoven H. W. M. Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction Best practice & research. Clinical gastroenterology 2016;30 (4):551-563 [PubMed]
  • van der Woude Stephanie O., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M. CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study Chinese clinical oncology 2016;5 (1):UNSP 13 [PubMed]
  • Haj Mohammad Nadia Daily clinical practice and patterns of care in upper gastrointestinal cancer treatment 2016. 271p. ISBN 9789462334649. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven H. W. M., Lemmens V. E. P. P.; Co-supervisors: van Oijen M. G. H., Hulshof M. C. C. M.)
  • Gerritsen Arja, Jacobs Marc, Henselmans Inge, van Hattum Jons, Efficace Fabio, Creemers Geert-Jan, de Hingh Ignace H., Koopman Miriam, Molenaar I. Quintus, Wilmink Hanneke W., Busch Olivier R., Besselink Marc G., van Laarhoven Hanneke W. Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey European journal of cancer (Oxford, England 2016;57:68-77 [PubMed]
  • Machiels Melanie, Wouterse Sanne J., Geijsen Elisabeth D., van Os Rob M., Bennink Roel J., van Laarhoven Hanneke Wm, Hulshof Maarten Ccm Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy Journal of medical imaging and radiation oncology 2016;60 (4):520-527 [PubMed]
  • Creemers A., Ebbing E. A., Hooijer G. K. J., Jibodh-Mulder A. R. A., Gisbertz S. S., van Oijen M. G. H., Henegouwen M. Ivan Berge, Bijlsma M. F., Meijer S. L., van Laarhoven H. W. M. Dynamics of the HER2 receptor in esophageal adenocarcinoma: New opportunities for targeted therapy Annals of oncology 2016;27:vi227
  • Haverkamp L., Parry K., van Berge Henegouwen M. I., van Laarhoven H. W., Bonenkamp J. J., Bisseling T. M., Siersema P. D., Sosef M. N., Stoot J. H., Beets G. L., de Steur W. O., Hartgrink H. H., Verspaget H. W., van der Peet D. L., Plukker J. T., van Etten B., Wijnhoven B. P. L., van Lanschot J. J., van Hillegersberg R., Ruurda J. P. Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands Diseases of the esophagus 2016;29 (5):435-441 [PubMed]
  • Rombouts S. J., Mungroop T. H., Heilmann M. N., van Laarhoven H. W., Busch O. R., Molenaar I. Q., Besselink M. G., Wilmink J. W. FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study Journal of Cancer 2016;7 (13):1861-1866 [PubMed]
  • Bernards N., Haj Mohammad N., Creemers G. J., Rozema T., Roukema J. A., Nieuwenhuijzen G. A. P., van Laarhoven H. W. M., van der Sangen M., Lemmens V. E. P. P. Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013 Acta oncologica (Stockholm, Sweden) 2016;55 (9-10):1161-1167 [PubMed]
  • de Groot Stefanie, Charehbili Ayoub, van Laarhoven Hanneke W. M., Mooyaart Antien L., Dekker-Ensink N. Geeske, van de Ven Saskia, Janssen Laura G. M., Swen Jesse J., Smit Vincent T. H. B. M., Heijns Joan B., Kessels Lonneke W., van der Straaten Tahar, Böhringer Stefan, Gelderblom Hans, van der Hoeven Jacobus J. M., Guchelaar Henk-Jan, Pijl Hanno, Kroep Judith R. Insulin-like growth factor 1 receptor expression and IGF1R 3129G  > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01) Breast cancer research 2016;18 (1):3 [PubMed]
  • Hidding Janine T., Viehoff Peter B., Beurskens Carien H. G., van Laarhoven Hanneke W. M., Nijhuis-van der Sanden Maria W. G., van der Wees Philip J. Measurement Properties of Instruments for Measuring of Lymphedema: Systematic Review Physical therapy 2016;96 (12):1965-1981 [PubMed]
  • Gurney-Champion Oliver J., Froeling Martijn, Klaassen Remy, Runge Jurgen H., Bel Arjan, van Laarhoven Hanneke W. M., Stoker Jaap, Nederveen Aart J. Minimizing the Acquisition Time for Intravoxel Incoherent Motion Magnetic Resonance Imaging Acquisitions in the Liver and Pancreas Investigative radiology 2016;51 (4):211-220 [PubMed]
  • Hillen Marij A., de Haes Hanneke C. J. M., van Tienhoven Geertjan, van Laarhoven Hanneke W. M., van Weert Julia C. M., Vermeulen Daniëlle M., Smets Ellen M. A. Oncologists' non-verbal behavior and analog patients' recall of information Acta oncologica (Stockholm, Sweden) 2016;55 (6):671-679 [PubMed]
  • Visser Annemiek, van Laarhoven Hanneke W. M., Woldringh Gwendolyn H., Hoogerbrugge Nicoline, Prins Judith B. Peer support and additional information in group medical consultations (GMCs) for BRCA1/2 mutation carriers: A randomized controlled trial Acta oncologica (Stockholm, Sweden) 2016;55 (2):178-187 [PubMed]
  • Kruizinga R., Helmich E., Schilderman J. B. A. M., Scherer-Rath M., van Laarhoven H. W. M. Professional identity at stake: a phenomenological analysis of spiritual counselors' experiences working with a structured model to provide care to palliative cancer patients Supportive care in cancer 2016;24 (7):3111-3118 [PubMed]
  • Lagarde S. M., Navidi M., Gisbertz S. S., van Laarhoven H. W. M., Sumpter K., Meijer S. L., Disep B., Immanuel A., Griffin S. M., van Berge Henegouwen M. I. Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy British journal of surgery 2016;103 (12):1658-1664 [PubMed]
  • Anderegg Maarten C. J., Lagarde Sjoerd M., Jagadesham Vamshi P., Gisbertz Suzanne S., Immanuel Arul, Meijer Sybren L., Hulshof Maarten C. C. M., Bergman Jacques J. G. H. M., van Laarhoven Hanneke W. M., Griffin S. Michael, van Berge Henegouwen Mark I. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction Annals of surgery 2016;264 (5):847-853 [PubMed]
  • van Rijssen Lennart B., Narwade Poorvi, van Huijgevoort Nadine C. M., Tseng Dorine S. J., van Santvoort Hjalmar C., Molenaar Isaac Q., van Laarhoven Hanneke W. M., van Eijck Casper H. J., Busch Olivier R. C., Besselink Marc G. H. Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis HPB: The official journal of the International Hepato Pancreato Biliary Association 2016;18 (7):559-566 [PubMed]
  • Gurney-Champion Oliver J., Bruins Slot Thijs, Lens Eelco, van der Horst Astrid, Klaassen Remy, van Laarhoven Hanneke W. M., van Tienhoven Geertjan, van Hooft Jeanin E., Nederveen Aart J., Bel Arjan Quantitative assessment of biliary stent artifacts on MR images: Potential implications for target delineation in radiotherapy Medical physics 2016;43 (10):5603 [PubMed]
  • ter Voert Edwin E. G. W., Heijmen Linda, Punt Cornelis J. A., de Wilt Johannes H. W., van Laarhoven Hanneke W. M., Heerschap Arend Reduced respiratory motion artifacts using structural similarity in fast 2D dynamic contrast enhanced MRI of liver lesions NMR in biomedicine 2016;29 (11):1526-1535 [PubMed]
  • Gurney-Champion Oliver J., Nederveen Aart J., Klaassen Remy, Engelbrecht Marc R., Bel Arjan, van Laarhoven Hanneke W. M., Stoker Jaap, Goncalves Sonia I. Revisiting the Potential of Alternating Repetition Time Balanced Steady-State Free Precession Imaging of the Abdomen at 3 T Investigative radiology 2016;51 (9):560-568 [PubMed]
  • ter Veer Emil, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. S-1 with leucovorin and oxaliplatin for advanced gastric cancer lancet oncology 2016;17 (2):E41 [PubMed]
  • ter Veer Emil, Haj Mohammad Nadia, van Valkenhoef Gert, Ngai Lok Lam, Mali Rosa M. A., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature Cancer metastasis reviews 2016;35 (3):439-456 [PubMed]
  • Kruizinga Renske, Hartog Iris D., Jacobs Marc, Daams Joost G., Scherer-Rath Michael, Schilderman Johannes B. A. M., Sprangers Mirjam A. G., van Laarhoven Hanneke W. M. The effect of spiritual interventions addressing existential themes using a narrative approach on quality of life of cancer patients: a systematic review and meta-analysis Psycho-oncology 2016;25 (3):253-265 [PubMed]
  • ter Veer Emil, Haj Mohammad Nadia, van Valkenhoef Gert, Ngai Lok Lam, Mali Rosa M. A., Anderegg Maarten C., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis Journal of the National Cancer Institute 2016;108 (10):djw166 [PubMed]
  • ter Veer Emil, Haj Mohammad Nadia, Lodder Paul, Ngai Lok Lam, Samaan Mary, van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis Gastric cancer 2016;19 (3):696-712 [PubMed]
  • de Vries Yfke C., Helmich Esther, Karsten Matty D. A., Boesveldt Sanne, Winkels Renate M., van Laarhoven Hanneke W. M. The impact of chemosensory and food-related changes in patients with advanced oesophagogastric cancer treated with capecitabine and oxaliplatin: a qualitative study Supportive care in cancer 2016;24 (7):3119-3126 [PubMed]
  • Bakens Maikel J., van der Geest Lydia G., van Putten Magreet, van Laarhoven Hanneke W., Creemers Geert-Jan, Besselink Marc G., Lemmens Valery E., de Hingh Ignace H. The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis Cancer medicine 2016;5 (10):2825-2831 [PubMed]
  • Charehbili A., Hamdy N. A. T., Smit V. T. H. B. M., Kessels L., van Bochove A., van Laarhoven H. W., Putter H., Meershoek-Klein Kranenbarg E., van Leeuwen-Stok A. E., van der Hoeven J. J. M., van de Velde C. J. H., Nortier J. W. R., Kroep J. R. Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01) Breast (Edinburgh, Scotland) 2016;25:69-74 [PubMed]
  • Haj Mohammad N., Bernards N., Besselink M. G. H., Busch O. R., Wilmink J. W., Creemers G. J. M., de Hingh I. H. J. T., Lemmens V. E. P. P., van Laarhoven H. W. M. Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands Journal of cancer research and clinical oncology 2016;142 (6):1353-1360 [PubMed]

2015

  • Anderegg Maarten C. J., de Groof Elisabeth J., Gisbertz Suzanne S., Bennink Roel J., Lagarde Sjoerd M., Klinkenbijl Jean H. G., Dijkgraaf Marcel G. W., Bergman Jacques J. G. H. M., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I. 18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making PLoS ONE 2015;10 (11):e0133690 [PubMed]
  • Noordman Bo Jan, Shapiro Joel, Spaander Manon C. W., Krishnadath Kausilia K., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I., Nieuwenhuijzen Grard A. P., van Hillegersberg Richard, Sosef Meindert N., Steyerberg Ewout W., Wijnhoven Bas P. L., van Lanschot J. Jan B., Shapiro Joël, Biermann Katharina, van der Gaast Ate, Krak Nanda C., van Rij Caroline, Valkema Roelf, Bennink Roel J., Hulshof Maarten C. C. M., Meijer Sybren L., Haj Mohammad Nadia, Hobbelink Monique G. G., van Leeuwen Maarten S., Offerhaus G. Johan A., Reerink Onne, Siersema Peter D., Creemers Geert-Jan, Roef Mark J., van der Sangen Maurice J. C., Schoon Erik J., Buijsen Jeroen, Nap Marius, Oostenbrug Liekele, Schreurs Wendu M. J., Warmerdam Fabienne A. R. M. Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol JMIR research protocols 2015;4 (2):e79 [PubMed]
  • Hillen Marij A., de Haes Hanneke C. J. M., van Tienhoven Geertjan, Bijker Nina, van Laarhoven Hanneke W. M., Vermeulen Daniëlle M., Smets Ellen M. A. All eyes on the patient: the influence of oncologists' nonverbal communication on breast cancer patients' trust Breast cancer research and treatment 2015;153 (1):161-171 [PubMed]
  • Visser Annemiek, de Witte Tim, Speckens Anne E. M., Prins Judith B., van Laarhoven Hanneke W. M. A qualitative analysis of experiences of patients with metastatic breast cancer participating in a mindfulness-based intervention Palliative medicine 2015;29 (2):182-183 [PubMed]
  • Salm L. P., Bulten B. F., van Laarhoven H. W. M., de Geus-Oei L. F. Autonomic Imaging Cardiotoxicity with [123I]-MIBG: The Effects of Chemotherapy, Monoclonal Antibody Therapy, and Radiotherapyin: Riemer H. J. A. Slart, René A. Tio, Philip H. Elsinga, Markus Schwaiger, editors. Autonomic Innervation of the Heart : Role of Molecular Imaging. New York: Springer; 2015. p. 437-453, ISBN 9783662450734; 9783662450741
  • Damhofer Helene, Veenstra Veronique L., Tol Johanna A. M. G., van Laarhoven Hanneke W. M., Medema Jan Paul, Bijlsma Maarten F. Blocking Hedgehog release from pancreatic cancer cells increases paracrine signaling potency Journal of cell science 2015;128 (1):129-139 [PubMed]
  • Visser Annemiek, Bos Wilmy C. A. M., Prins Judith B., Hoogerbrugge Nicoline, van Laarhoven Hanneke W. M. Breast self-examination education for BRCA mutation carriers by clinical nurse specialists Clinical nurse specialist CNS 2015;29 (3):E1-E7 [PubMed]
  • Haj Mohammad N., Walter A. W., van Oijen M. G. H., Hulshof M. C. C. M., Bergman J. J. G. H. M., Anderegg M. C. J., van Berge Henegouwen M. I., Henselmans I., Sprangers M. A. G., van Laarhoven H. W. M. Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent Supportive care in cancer 2015;23 (12):3589-3598 [PubMed]
  • Henselmans Inge, Smets Ellen M. A., van Laarhoven Hanneke W. M. Decision Making About Treatment for Advanced Cancer: InfluencingWisely? JAMA oncology 2015;1 (8):1169 [PubMed]
  • Versteijne E., van Laarhoven H. W. M., van Hooft J. E., van Os R. M., Geijsen E. D., van Berge Henegouwen M. I., Hulshof M. C. C. M. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern Diseases of the esophagus 2015;28 (5):453-459 [PubMed]
  • Machiels Melanie, van Hooft Jeanin, Jin Peng, van Berge Henegouwen Mark I., van Laarhoven Hanneke M., Alderliesten Tanja, Hulshof Maarten C. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers Gastrointestinal endoscopy 2015;82 (4):641-649 [PubMed]
  • Damhofer Helene, Ebbing Eva A., Steins Anne, Welling Lieke, Tol Johanna A., Krishnadath Kausilia K., van Leusden Tom, van de Vijver Marc J., Besselink Marc G., Busch Olivier R., van Berge Henegouwen Mark I., van Delden Otto, Meijer Sybren L., Dijk Frederike, Medema Jan Paul, van Laarhoven Hanneke W., Bijlsma Maarten F. Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract Journal of translational medicine 2015;13 (1):115 [PubMed]
  • Klaassen Remy, Bennink Roelof J., van Tienhoven Geertjan, Bijlsma Maarten F., Besselink Marc G. H., van Berge Henegouwen Mark I., Wilmink Johanna W., Nederveen Aart J., Windhorst Albert D., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M. Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer Radiotherapy and oncology 2015;116 (1):94-99 [PubMed]
  • Visser Annemiek, van Laarhoven Hanneke W. M., Govaert Paulien H. M., Schlooz Margrethe S., Jansen Lisette, van Dalen Thijs, Prins Judith B. Group medical consultations in the follow-up of breast cancer: a randomized feasibility study Journal of cancer survivorship 2015;9 (3):450-461 [PubMed]
  • Prinsen Hetty, van Laarhoven Hanneke W. M., Pots Jeanette M., Duiveman-de Boer Tjitske, Mulder Sasja F., van Herpen Carla M. L., Jacobs Joannes F. M., Leer Jan Willem H., Bleijenberg Gijs, Stelma Foekje F., Torensma Ruurd, de Vries I. Jolanda M. Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue Human vaccines & immunotherapeutics 2015;11 (7):1634-1640 [PubMed]
  • Onstenk Wendy, Kraan Jaco, Mostert Bianca, Timmermans Mieke M., Charehbili Ayoub, Smit Vincent T. H. B. M., Kroep Judith R., Nortier Johan W. R., van de Ven Saskia, Heijns Joan B., Kessels Lonneke W., van Laarhoven Hanneke W. M., Bos Monique M. E. M., van de Velde Cornelis J. H., Gratama Jan W., Sieuwerts Anieta M., Martens John W. M., Foekens John A., Sleijfer Stefan Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy Molecular cancer therapeutics 2015;14 (3):821-827 [PubMed]
  • Span P. N., Pollakis G., Paxton W. A., Sweep F. C. G. J., Foekens J. A., Martens J. W. M., Sieuwerts A. M., van Laarhoven H. W. M. Improved metastasis-free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations International journal of cancer. Journal international du cancer 2015;136 (1):91-97 [PubMed]
  • van Uden D. J. P., van Laarhoven H. W. M., Westenberg A. H., de Wilt J. H. W., Blanken-Peeters C. F. J. M. Inflammatory breast cancer: an overview Critical reviews in oncology/hematology 2015;93 (2):116-126 [PubMed]
  • Spierings L. E. A. M. M., Lagarde S. M., van Oijen M. G. H., Gisbertz S. S., Wilmink J. W., Hulshof M. C. C. M., Meijer S. L., Anderegg M. C., van Berge Henegouwen M. I., van Laarhoven H. W. M. Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes Annals of surgical oncology 2015;22 (Suppl. 3):S766-S771 [PubMed]
  • Heijmen Linda, ter Voert Edwin E. G. W., Oyen Wim J. G., Punt Cornelis J. A., van Spronsen Dick Johan, Heerschap Arend, de Geus-Oei Lioe-Fee, van Laarhoven Hanneke W. M. Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer PLoS ONE 2015;10 (4):e0120823 [PubMed]
  • Shapiro Joel, van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Hagen Pieter, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., ten Kate Fiebo J. W., Creemers Geert-Jan M., Punt Cornelis J. A., Plukker John Th M., Verheul Henk M. W., Bilgen Ernst J. Spillenaar, van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., Steyerberg Ewout W., van der Gaast Ate Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial lancet oncology 2015;16 (9):1090-1098 [PubMed]
  • van Boxtel W., Bulten B. F., Mavinkurve-Groothuis A. M. C., Bellersen L., Mandigers C. M. P. W., Joosten L. A. B., Kapusta L., de Geus-Oei L. F., van Laarhoven H. W. M. New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide Biomarkers 2015;20 (2):143-148 [PubMed]
  • Haj Mohammad N., ter Veer E., Ngai L., Mali R., van Oijen M. G. H., van Laarhoven H. W. M. Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis Cancer metastasis reviews 2015;34 (3):429-441 [PubMed]
  • Visser Annemiek Professional and peer support in breast cancer care and BRCA surveillanceNijmegen: Optima Grafische Communicatie, Rotterdam; 2015. 171p. ISBN 9789461697547. [UvA Dissertations Online] Radboud Institute for Health and Sciences: Medical Psychology. (Supervisors: Prins J. B., Hoogerbrugge N.; Co-supervisor: van Laarhoven H. M. W.)
  • Haj Mohammad Nadia, Kamphuis Martijn, Hulshof Maarten C. C. M., Lutkenhaus Lotte J., Gisbertz Suzanne S., Bergman Jacques J. G. H. M., de Bruin-Bon Rianne H. A. C. M., Geijsen Elisabeth D., Bel Arjan, Boekholdt S. Mathijs, van Laarhoven Hanneke W. M. Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer Radiotherapy and oncology 2015;114 (1):91-95 [PubMed]
  • Bulten Ben F., Verberne Hein J., Bellersen Louise, Oyen Wim J. G., Sabaté-Llobera Aida, Mavinkurve-Groothuis Annelies M. C., Kapusta Livia, van Laarhoven Hanneke W. M., de Geus-Oei Lioe-Fee Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients Cancer chemotherapy and pharmacology 2015;76 (5):957-967 [PubMed]
  • Custers J. A. E., Becker E. S., Gielissen M. F. M., van Laarhoven H. W. M., Rinck M., Prins J. B. Selective Attention and Fear of Cancer Recurrence in Breast Cancer Survivors Annals of behavioral medicine 2015;49 (1):66-73 [PubMed]
  • Bernards Nienke, Haj Mohammad Nadia, Creemers Geert-Jan, de Hingh Ignace H. J. T., van Laarhoven Hanneke W. M., Lemmens Valery E. P. P. Ten weeks to live: A population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands Acta oncologica (Stockholm, Sweden) 2015;54 (3):403-410 [PubMed]
  • Bijlsma Maarten F., van Laarhoven Hanneke W. M. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal Cancer metastasis reviews 2015;34 (1):97-114 [PubMed]
  • Welzen Marieke E. B., Dezentjé Vincent O., van Schaik Ron H. N., Colbers Angela P. H., Guchelaar Henk-Jan, van Erp Nielka P., den Hartigh Jan, Burger David M., van Laarhoven Hanneke W. M. The Effect of Tamoxifen Dose Increment in Patients With Impaired CYP2D6 Activity Therapeutic drug monitoring 2015;37 (4):501-507 [PubMed]
  • Brown Patrick, de Graaf Sabine, Hillen Marij, Smets Ellen, van Laarhoven Hanneke The interweaving of pharmaceutical and medical expectations as dynamics of micro-pharmaceuticalisation: advanced-stage cancer patients' hope in medicines alongside trust in professionals Social science & medicine (1982) 2015;131:313-321 [PubMed]
  • Prinsen Hetty, van Dijk Johannes P., Zwarts Machiel J., Leer Jan Willem H., Bleijenberg Gijs, van Laarhoven Hanneke W. M. The role of central and peripheral muscle fatigue in postcancer fatigue: a randomized controlled trial Journal of pain and symptom management 2015;49 (2):173-182 [PubMed]
  • de Groot S., Janssen L. G. M., Charehbili A., Dijkgraaf E. M., Smit V. T. H. B. M., Kessels L. W., van Bochove A., van Laarhoven H. W. M., Meershoek-Klein Kranenbarg E., van Leeuwen-Stok A. E., van de Velde C. J. H., Putter H., Nortier J. W. R., van der Hoeven J. J. M., Pijl H., Kroep J. R. Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01) Breast cancer research and treatment 2015;149 (2):461-466 [PubMed]
  • Heskamp Sandra, Boerman Otto C., Molkenboer-Kuenen Janneke D. M., Wauters Carla A., Strobbe Luc J. A., Mandigers Caroline M. P. W., Bult Peter, Oyen Wim J. G., van der Graaf Winette T. A., van Laarhoven Hanneke W. M. Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients PLoS ONE 2015;10 (2):e0117745 [PubMed]

2014

  • Haj Mohammad Nadia, Hulshof Maarten C. C. M., Bergman Jacques J. G. H. M., Geijsen Debby, Wilmink Johanna W., van Berge Henegouwen Mark I., van Laarhoven Hanneke W. M. Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma BMC cancer 2014;14 (1):56 [PubMed]
  • Charehbili A., van de Ven S., Smit V. T. H. B. M., Meershoek-Klein Kranenbarg E., Hamdy N. A. T., Putter H., Heijns J. B., van Warmerdam L. J. C., Kessels L., Dercksen M., Pepels M. J., Maartense E., van Laarhoven H. W. M., Vriens B., Wasser M. N., van Leeuwen-Stok A. E., Liefers G. J., van de Velde C. J. H., Nortier J. W. R., Kroep J. R. Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01) Annals of oncology 2014;25 (5):998-1004 [PubMed]
  • Sprangers Mirjam A. G., Thong Melissa S. Y., Bartels Meike, Barsevick Andrea, Ordoñana Juan, Shi Qiuling, Wang Xin Shelley, Klepstad Pål, Wierenga Eddy A., Singh Jasvinder A., Sloan Jeff A., Abertnethy Amy P., Baas Frank, Barsevick Andrea M., Boomsma Dorret I., Bottomley Andrew, Brundage Michael, Cella David, Chauhan Cynthia, Cleeland Charles S., Coens Corneel, Dueck Amylou C., Frost Marlene H., Hall Per, Halyard Michele Y., van Laarhoven Hanneke W. M., Martin Nicholas G., Miaskowski Christine, Mosing Miriam, Movsas Benjamin, Oliveira Joao R., Patrick Donald L., Pedersen Nancy L., Raat Hein, Reeve Bryce, Stephen Ristvedt, Ropka Mary E., Schwartz Carolyn, Shi Quiling, Shinozaki Gen, Swaab Dick, Talwalkar Jayant, Thong Melissa, van Noorden Cornelis J. F., Veenhoven Ruut, Wagner Gert, Wierenga Eddy, Yang Ping, Zwinderman Ailko H. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update Quality of life research 2014;23 (7):1997-2013 [PubMed]
  • Heskamp Sandra, Boerman Otto C., Molkenboer-Kuenen Janneke D. M., Sweep Fred C. G. J., Geurts-Moespot Anneke, Engelhardt Mallory S., van der Graaf Winette T. A., Oyen Wim J. G., van Laarhoven Hanneke W. M. Cetuximab Reduces the Accumulation of Radiolabeled Bevacizumab in Cancer Xenografts without Decreasing VEGF Expression Molecular pharmaceutics 2014;11 (11):4249-4257 [PubMed]
  • ter Voert Edwin E. G. W., van Laarhoven Hanneke W. M., Kok Peter J. M., Oyen Wim J. G., Visser Eric P., de Geus-Oei Lioe-Fee Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in (18)F-FDG PET/CT Nuclear medicine communications 2014;35 (5):472-477 [PubMed]
  • Vivat B., Young T., Winstanley J., Arraras J. I., Bennett M. I., Brédart A., Costantini A., Fisher S. E., Greimel E., Guo J., Irarrazaval M. E., Kobayashi K., Kruizinga R., Navarro M., Omidvari S., Rohde G. E., Serpentini S., van Laarhoven H. W. M., Yang G. Development and validation of a cross-cultural EORTC measure of spiritual wellbeing (swb) for palliative care patients with cancer BMJ supportive & palliative care 2014;4 (1):109 [PubMed]
  • Heskamp Sandra, Boerman Otto C., Molkenboer-Kuenen Janneke D. M., Koornstra Rutger H. T., Linn Sabine C., Oyen Wim J. G., van der Graaf Winette T. A., van Laarhoven Hanneke W. M. Dynamics of IGF-1R Expression During Endocrine Breast Cancer Treatment Molecular imaging and biology : MIB 2014;16 (4):529-537 [PubMed]
  • Bulten Ben F., Mavinkurve-Groothuis Annelies M. C., de Geus-Oei Lioe-Fee, de Haan Anton F. J., de Korte Chris L., Bellersen Louise, van Laarhoven Hanneke W. M., Kapusta Livia Early myocardial deformation abnormalities in breast cancer survivors Breast cancer research and treatment 2014;146 (1):127-135 [PubMed]
  • Hillen M. A., de Haes H. C. J. M., Stalpers L. J. A., Klinkenbijl J. H. G., Eddes E. H., Butow P. N., van der Vloodt J., van Laarhoven H. W. M., Smets E. M. A. How can communication by oncologists enhance patients' trust? An experimental study Annals of oncology 2014;25 (4):896-901 [PubMed]
  • Koen Talsma A., Shapiro Joel, Looman Caspar W. N., van Hagen Pieter, Steyerberg Ewout W., van der Gaast Ate, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., ten Kate Fiebo J. W., Creemers Geert-Jan, Punt Cornelis J. A., Plukker John T. M., Verheul Henk M. W., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., van Rij Caroline Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival Annals of surgery 2014;260 (5):786-92; discussion 792-3 [PubMed]
  • van Uden Dominique J. P., Westenberg A. H. Helen, van Laarhoven Hanneke W. M., Meijer Jos W. R., de Wilt J. H. W. Hans, Blanken-Peeters Charlotte F. J. M. Mastitis als uiting van een maligniteit Nederlands tijdschrift voor geneeskunde 2014;158:A7591 [PubMed]
  • Heskamp S. Molecular imaging of receptor tyrosine kinases in cancer 2014. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Geneeskunde. (Supervisors: Boerman O., van der Graaf W. T., Oyen W.; Co-supervisor: van Laarhoven H. W. M.)
  • Heijmen L., ter Voert E. G. W., Punt C. J. A., Heerschap A., Oyen W. J. G., Bussink J., Sweep C. G. J., Laverman P., Span P. N., de Geus-Oei L. F., Boerman O. C., van Laarhoven H. W. M. Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model Contrast media & molecular imaging 2014;9 (3):237-245 [PubMed]
  • Heijmen Linda Multimodality Imaging in colorectal cancerNijmegen: 2014. 186p. ISBN 9789461088260. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Medische Oncology. (Supervisor: Punt C. J. A.; Co-supervisors: van Laarhoven H. M. W., de Geus-Oei L. F.)
  • Kordes Sil, van Berge Henegouwen Mark I., Hulshof Maarten C., Bergman Jacques J. G. H. M., van der Vliet Hans J., Kapiteijn Ellen, van Laarhoven Hanneke W. M., Richel Dick J., Klinkenbijl Jean H. G., Meijer Sybren L., Wilmink Johanna W. Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study International journal of radiation oncology, biology, physics 2014;90 (1):190-196 [PubMed]
  • Shapiro Joel, van Hagen Pieter, Lingsma Hester F., Wijnhoven Bas P. L., Biermann Katharina, ten Kate Fiebo J. W., Steyerberg Ewout W., van der Gaast Ate, van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Berge Henegouwen Mark I., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., Creemers Geert-Jan, Punt Cornelis J. A., Plukker John T. M., Verheul Henk M. W., Spillenaar Bilgen Ernst J., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W. Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer Annals of surgery 2014;260 (5):807-814 [PubMed]
  • Grebenchtchikov Nicolai, Geurts-Moespot Anneke J., Heijmen Linda, van Laarhoven Hanneke W. M., van Herpen Carla M. L., Thijs Annemarie M. J., Span Paul N., Sweep Fred C. G. J. Quantification of patient-specific assay interference in different formats of enzyme-linked immunoassays for therapeutic monoclonal antibodies Therapeutic drug monitoring 2014;36 (6):765-770 [PubMed]
  • Heskamp Sandra, van Laarhoven Hanneke W. M., van der Graaf Winette T. A., Oyen Wim J. G., Boerman Otto C. Radionuclide imaging of drug delivery for patient selection in targeted therapy Expert opinion on drug delivery 2014;11 (2):175-185 [PubMed]
  • Drukker C. A., van den Hout H. C., Sonke G. S., Brain E., Bonnefoi H., Cardoso F., Goldhirsch A., Harbeck N., Honkoop A. H., Koornstra R. H. T., van Laarhoven H. W. M., Portielje J. E. A., Schneeweiss A., Smorenburg C. H., Stouthard J., Linn S. C., Schmidt M. K. Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signature European journal of cancer (Oxford, England 2014;50 (6):1045-1054 [PubMed]
  • Kordes S., Cats A., Meijer S. L., van Laarhoven H. W. M. Targeted therapy for advanced esophagogastric adenocarcinoma Critical reviews in oncology/hematology 2014;90 (1):68-76 [PubMed]
  • Custers José A. E., van den Berg Sanne W., van Laarhoven Hanneke W. M., Bleiker Eveline M. A., Gielissen Marieke F. M., Prins Judith B. The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors Cancer nursing 2014;37 (1):E44-E50 [PubMed]
  • van Laarhoven Hanneke W. M., Henselmans Inge, de Haes J. Hanneke C. To treat or not to treat: who should decide? oncologist 2014;19 (4):433-436 [PubMed]
  • Hidding Janine T., Beurskens Carien H. G., van der Wees Philip J., van Laarhoven Hanneke W. M., Nijhuis-van der Sanden Maria W. G. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review PLoS ONE 2014;9 (5):e96748 [PubMed]

2013

  • Hendriks Mathijs P., Driessen Chantal M. L., van Laarhoven Hanneke W. M., Janssens Geert O. R. J., Verbist Berit M., van der Graaf Winette T. A., Slootweg Piet J., Merkx Matthias A. W., van Herpen Carla M. L. Aggressive fibromatosis in the head and neck region: Benign tumor with often mutilating effects Head & neck 2013;35 (8):E246-E250 [PubMed]
  • Boonstra Amilie, van Zadelhoff Joost, Timmer-Bonte Anja, Ottevanger Petronella B., Beurskens Carien H. G., van Laarhoven Hanneke W. M. Arthralgia During Aromatase Inhibitor Treatment in Early Breast Cancer Patients Prevalence, Impact, and Recognition by Healthcare Providers Cancer nursing 2013;36 (1):52-59 [PubMed]
  • Heskamp Sandra, Boerman Otto C., Molkenboer-Kuenen Janneke D. M., Oyen Wim J. G., van der Graaf Winette T. A., van Laarhoven Hanneke W. M. Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies International journal of cancer. Journal international du cancer 2013;133 (2):307-314 [PubMed]
  • Mann R. M., Bult P., van Laarhoven H. W. M., Span P. N., Schlooz M., Veltman J., Hoogerbrugge N. Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients European journal of radiology 2013;82 (9):1416-1422 [PubMed]
  • van der Palen R. L. F., Bulten B. F., Mavinkurve-Groothuis A. M. C., Bellersen L., van Laarhoven H. W. M., Kapusta L., de Geus-Oei L. F. Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patients Nuklearmedizin 2013;52 (6):228-234 [PubMed]
  • Aarts Maureen J., Grutters Janneke P., Peters Frank P., Mandigers Caroline M., Dercksen M. Wouter, Stouthard Jacqueline M., Nortier Hans J., van Laarhoven Hanneke W., van Warmerdam Laurence J., van de Wouw Agnes J., Jacobs Esther M., Mattijssen Vera, van der Rijt Carin C., Smilde Tineke J., van der Velden Annette W., Temizkan Mehmet, Batman Erdogan, Muller Erik W., van Gastel Saskia M., Joore Manuela A., Borm George F., Tjan-Heijnen Vivianne C. Cost Effectiveness of Primary Pegfilgrastim Prophylaxis in Patients With Breast Cancer at Risk of Febrile Neutropenia Journal of clinical oncology 2013;31 (34):4283-4289 [PubMed]
  • Heijmen Linda, ter Voert Edwin E. G. W., Nagtegaal Iris D., Span Paul, Bussink Johan, Punt Cornelis J. A., de Wilt Johannes H. W., Sweep Fred C. G. J., Heerschap Arend, van Laarhoven Hanneke W. M. Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation European radiology 2013;23 (3):748-756 [PubMed]
  • Ploos van Amstel Floortje K., van den Berg Sanne W., van Laarhoven Hanneke W. M., Gielissen Marieke F. M., Prins Judith B., Ottevanger Petronella B. Distress screening remains important during follow-up after primary breast cancer treatment Supportive care in cancer 2013;21 (8):2107-2115 [PubMed]
  • Prinsen Hetty Fatigue in cancer survivors: a (neuro)physiological approach 2013. [UvA Dissertations Online] Radboud Universiteit: Medische oncologie. (Supervisors: Blijenberg G., Heerschap A.; Co-supervisor: van Laarhoven H. W. M.)
  • Wennemers Marloes, Stegeman Hanneke, Bussink Johan, Versleijen-Jonkers Yvonne M. H., van Laarhoven Hanneke W. M., Raleigh James A., Varia Mahesh A., Sweep Fred C. G. J., Span Paul N. Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer International journal of biological markers 2013;28 (2):151-160 [PubMed]
  • Prinsen Hetty, Heerschap Arend, Bleijenberg Gijs, Zwarts Machiel J., Leer Jan Willem H., van Asten Jack J., van der Graaf Marinette, Rijpkema Mark, van Laarhoven Hanneke W. M. Magnetic resonance spectroscopic imaging and volumetric measurements of the brain in patients with postcancer fatigue: a randomized controlled trial PLoS ONE 2013;8 (9):e74638 [PubMed]
  • Prinsen H., Hopman M. T. E., Zwarts M. J., Leer J. W. H., Heerschap A., Bleijenberg G., van Laarhoven H. W. M. Maximal exercise performance in patients with postcancer fatigue Supportive care in cancer 2013;21 (2):439-447 [PubMed]
  • Heijmen L., Punt C. J. A., ter Voert E. G. W., de Geus-Oei L. F., Heerschap A., Bussink J., Sweep C. G. J., Zerbi V., Oyen W. J. G., Span P. N., Boerman O., van Laarhoven H. W. M. Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach Investigational new drugs 2013;31 (4):881-890 [PubMed]
  • Aarts Maureen J., Peters Frank P., Mandigers Caroline M., Dercksen M. Wouter, Stouthard Jacqueline M., Nortier Hans J., van Laarhoven Hanneke W., van Warmerdam Laurence J., van de Wouw Agnes J., Jacobs Esther M., Mattijssen Vera, van der Rijt Carin C., Smilde Tineke J., van der Velden Annette W., Temizkan Mehmet, Batman Erdogan, Muller Erik W., van Gastel Saskia M., Borm George F., Tjan-Heijnen Vivianne C. G. Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia Journal of clinical oncology 2013;31 (34):4290-U20 [PubMed]
  • ter Voert E. G. W., Heijmen L., de Wilt J. H. W., Bussink J., Punt C. J. A., van Laarhoven H. W. M., Heerschap A. Reproducibility and Biological Basis of In Vivo T-2* Magnetic Resonance Imaging of Liver Metastasis of Colorectal Cancer Magnetic resonance in medicine 2013;70 (4):1145-1152 [PubMed]
  • de Geus-Oei Lioe-Fee, Mavinkurve-Groothuis Annelies M. C., Bellersen Louise, Gotthardt Martin, Oyen Wim J. G., Kapusta Livia, van Laarhoven Hanneke W. M. Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity Journal of nuclear medicine technology 2013;41 (3):170-181 [PubMed]
  • van Leeuwen René, Schep-Akkerman Annemiek, van Laarhoven Hanneke W. M. Screening Patient Spirituality and Spiritual Needs in Oncology Nursing Holistic nursing practice 2013;27 (4):207-216 [PubMed]
  • Alexandrov Ludmil B., Nik-Zainal Serena, Wedge David C., Aparicio Samuel A. J. R., Behjati Sam, Biankin Andrew V., Bignell Graham R., Bolli Niccolò, Borg Ake, Børresen-Dale Anne-Lise, Boyault Sandrine, Burkhardt Birgit, Butler Adam P., Caldas Carlos, Davies Helen R., Desmedt Christine, Eils Roland, Eyfjörd Jórunn Erla, Foekens John A., Greaves Mel, Hosoda Fumie, Hutter Barbara, Ilicic Tomislav, Imbeaud Sandrine, Imielinsk Marcin, Jäger Natalie, Jones David T. W., Jones David, Knappskog Stian, Kool Marcel, Lakhani Sunil R., López-Otín Carlos, Martin Sancha, Munshi Nikhil C., Nakamura Hiromi, Northcott Paul A., Pajic Marina, Papaemmanuil Elli, Paradiso Angelo, Pearson John V., Puente Xose S., Raine Keiran, Ramakrishna Manasa, Richardson Andrea L., Richter Julia, Rosenstiel Philip, Schlesner Matthias, Schumacher Ton N., Span Paul N., van Laarhoven Hanneke Signatures of mutational processes in human cancer Nature 2013;500 (7463):415-421 [PubMed]
  • Berends M., Lesterhuis W. J., van Laarhoven H. W. M. Streptozotocin-induced diabetic ketoacidosis in a patient with metastatic islet-cell carcinoma Netherlands journal of medicine 2013;71 (10):541-542 [PubMed]
  • Blom Rachel L., Lagarde Sjoerd M., van Oudenaarde Kim, Klinkenbijl Jean H. G., Hulshof Maarten C., van Laarhoven Hanneke W., Bergman Jacques J., Busch Olivier R., van Berge Henegouwen Mark I. Survival after recurrent esophageal carcinoma has not improved over the past 18 years Annals of surgical oncology 2013;20 (8):2693-2698 [PubMed]
  • de Visser M., Fluit C., Timmer-Bonte J., Ottevanger P., Verhagen C., Klaassen T., van Laarhoven H. W. M. Teaching adjuvant endocrine breast cancer treatment to medical students Netherlands journal of medicine 2013;71 (4):215-219 [PubMed]
  • Kruizinga Renske, Scherer-Rath Michael, Schilderman Johannes B. A. M., Sprangers Mirjam A. G., van Laarhoven Hanneke W. M. The life in sight application study (LISA): design of a randomized controlled trial to assess the role of an assisted structured reflection on life events and ultimate life goals to improve quality of life of cancer patients BMC cancer 2013;13 (1):360 [PubMed]
  • Prinsen H., Bleijenberg G., Heijmen L., Zwarts M. J., Leer J. W. H., Heerschap A., Hopman M. T. E., van Laarhoven H. W. M. The role of physical activity and physical fitness in postcancer fatigue: a randomized controlled trial Supportive care in cancer 2013;21 (8):2279-2288 [PubMed]
  • Fleuren Emmy D. G., Versleijen-Jonkers Yvonne M. H., Heskamp Sandra, Roeffen Melissa H. S., Bouwman Wilbert H., Molkenboer-Kuenen Janneke D. M., van Laarhoven Hanneke W. M., Oyen Wim J. G., Boerman Otto C., van der Graaf Winette T. A. The strength of small: Improved targeting of Insulin-like Growth Factor-1 Receptor (IGF-1R) with F(ab')2-R1507 fragments in Ewing sarcomas European journal of cancer (Oxford, England 2013;49 (13):2851-2858 [PubMed]
  • Heskamp S., van Laarhoven H. W. M., Oyen W. J. G., van der Graaf W. T. A., Boerman O. C. Tumor-receptor imaging in breast cancer: a tool for patient selection and response monitoring Current molecular medicine 2013;13 (10):1506-1522 [PubMed]
  • van de Schootbrugge Chantal, van Asten Freekje, Nagtegaal Iris D., Versleijen-Jonkers Yvonne M., van Laarhoven Hanneke W. M., Roeffen Melissa H., Sweep Fred C. G. J., Bussink Johan, Kaanders Johannes H. A. M., Pruijn Ger J. M., Boelens Wilbert C., Span Paul N. αB-crystallin expression is correlated with phospho-ERK1/2 expression in human breast cancer International journal of biological markers 2013;28 (4):e365-e370 [PubMed]

2012

  • van der Pluijm R. W., Lamers M. J., de Boer M., van der Graaf W. T. A., van Laarhoven H. W. M. A female with a leiomyosarcoma presenting with acute thoracic pain and dyspnoea Netherlands journal of medicine 2012;70 (8):377-380 [PubMed]
  • Francissen Claire M. T. P., Dings Pim J. M., van Dalen Thijs, Strobbe Luc J. A., van Laarhoven Hanneke W. M., de Wilt Johannes H. W. Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature Annals of surgical oncology 2012;19 (13):4140-4149 [PubMed]
  • van Laarhoven Hanneke W. M., Schilderman Johannes, Verhagen Constans A. H. H. V. M., Prins Judith B. Comparison of attitudes of guilt and forgiveness in cancer patients without evidence of disease and advanced cancer patients in a palliative care setting Cancer nursing 2012;35 (6):483-492 [PubMed]
  • Heijmen Linda, van Laarhoven Hanneke W. M., Punt Cornelis J. A., van den Hurk Desiree, van der Drift Miep A., Ottevanger Petronella B., Timmer-Bonte Johanna N. H. Encouraging results in older patients receiving chemotherapy: a retrospective analysis of treatment guideline adherence in daily practice Geriatrics & gerontology international 2012;12 (1):80-85 [PubMed]
  • Prinsen Hetty, de Vries I. Jolanda, Torensma Ruurd, Pots Jeanette M., Mulder Sasja F., van Herpen Carla M., Elving Lammy D., Bleijenberg Gijs, Stelma Foekje F., van Laarhoven Hanneke W. Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome BMC immunology 2012;13 (1):71 [PubMed]
  • Heskamp Sandra, Laverman Peter, Rosik Daniel, Boschetti Frederic, van der Graaf Winette T. A., Oyen Wim J. G., van Laarhoven Hanneke W. M., Tolmachev Vladimir, Boerman Otto C. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer Journal of nuclear medicine 2012;53 (1):146-153 [PubMed]
  • Starmans M. H. W., Lieuwes N. G., Span P. N., Haider S., Dubois L., Nguyen F., van Laarhoven H. W., Sweep F. C. G. J., Wouters B. G., Boutros P. C., Lambin P. Independent and functional validation of a multi-tumour-type proliferation signature British journal of cancer 2012;107 (3):508-515 [PubMed]
  • Heijmen L., Fütterer J. J., van Laarhoven H. W. M. Intra-thoracic mass on CT in a breast cancer patient Netherlands journal of medicine 2012;70 (6):283-+ [PubMed]
  • Bulten Ben F., van der Palen Roel L. F., van Laarhoven Hanneke W. M., Kapusta Livia, Mavinkurve-Groothuis Annelies M. C., de Geus-Oei Lioe-Fee Letter to the Editor: Interobserver Variability of Heart-to-Mediastinum Ratio in I-123 MIBG Sympathetic Imaging Current cardiology reports 2012;14 (4):389-390 [PubMed]
  • de Vos F. Y. F. L., van Laarhoven H. W. M., Laven J. S. E., Themmen A. P. N., Beex L. V. A. M., Sweep C. G. J., Seynaeve C., Jager A. Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline Critical reviews in oncology/hematology 2012;84 (2):252-260 [PubMed]
  • Heijmen Linda, van Dijk Ewoud J., Goraj Bozena, van Laarhoven Hanneke W. M. Moyamoya Disease Misdiagnosed As Leptomeningeal Metastases Journal of clinical oncology 2012;30 (36):E382-E385 [PubMed]
  • Heskamp Sandra, van Laarhoven Hanneke W. M., Molkenboer-Kuenen Janneke D. M., Bouwman Wilbert H., van der Graaf Winette T. A., Oyen Wim J. G., Boerman Otto C. Optimization of IGF-1R SPECT/CT Imaging Using In-111-Labeled F(ab ')(2) and Fab Fragments of Article the Monoclonal Antibody R1507 Molecular pharmaceutics 2012;9 (8):2314-2321 [PubMed]
  • Hendriks Mathijs P., van Laarhoven Hanneke W. M., van de Sande Ries, van Weel-Baumgarten Evelyn, Verhagen Constans A., Vissers Kris C. Palliative Care for an Islamic Patient: Changing Frameworks Journal of palliative medicine 2012;15 (10):1053-1055 [PubMed]
  • Prinsen Hetty, Bleijenberg Gijs, Zwarts Machiel J., Hopman Maria T. E., Heerschap Arend, van Laarhoven Hanneke W. M. Physiological and neurophysiological determinants of postcancer fatigue: design of a randomized controlled trial BMC cancer 2012;12 (1):256 [PubMed]
  • Heijmen Linda, de Geus-Oei Lioe-Fee, de Wilt Johannes H. W., Visvikis Dimitris, Hatt Mathieu, Visser Eric P., Bussink Johan, Punt Cornelis J. A., Oyen Wim J. G., van Laarhoven Hanneke W. M. Reproducibility of functional volume and activity concentration in F-18-FDG PET/CT of liver metastases in colorectal cancer European journal of nuclear medicine and molecular imaging 2012;39 (12):1858-1867 [PubMed]
  • de Vos F. Y. F. L., van Laarhoven H. M. W. Taxus baccata allergy in a breast cancer patient Netherlands journal of medicine 2012;70 (5):249 [PubMed]
  • Heijmen Linda, Verstappen Maartje C. H. M., ter Voert Edwin E. G. W., Punt Cornelis J. A., Oyen Wim J. G., de Geus-Oei Lioe-Fee, Hermans John J., Heerschap Arend, van Laarhoven Hanneke W. M. Tumour response prediction by diffusion-weighted MR imaging: Ready for clinical use? Critical reviews in oncology/hematology 2012;83 (2):194-207 [PubMed]

2011

  • Heijmen L., Vehof J., van Laarhoven H. W. M. Blistering of the hand in a breast cancer patient. Extravasation Netherlands journal of medicine 2011;69 (2):82, 85 [PubMed]
  • Nagelkerke Anika, van Kuijk Simon J. A., Sweep Fred C. G. J., Nagtegaal Iris D., Hoogerbrugge Nicoline, Martens John W. M., Timmermans Mieke A., van Laarhoven Hanneke W. M., Bussink Johan, Span Paul N. Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer Radiotherapy and oncology 2011;101 (1):39-45 [PubMed]
  • van Laarhoven Hanneke W. M., Schilderman Johannes, Bleijenberg Gijs, Donders Rogier, Vissers Kris C., Verhagen Constans A. H. H. V. M., Prins Judith B. Coping, quality of life, depression, and hopelessness in cancer patients in a curative and palliative, end-of-life care setting Cancer nursing 2011;34 (4):302-314 [PubMed]
  • Desar Ingrid M. E., van Herpen Carla M. L., van Asten Jack J. A., Fiedler Walter, Marreaud Sandrine, Timmer-Bonte Johanna N. H., ter Voert Edwin G. W., Lambiase Antonio, Bordignon Claudio, Heerschap Arend, van Laarhoven Hanneke W. M. Factors affecting the unexpected failure of DCE-MRI to determine the optimal biological dose of the vascular targeting agent NGR-hTNF in solid cancer patients European journal of radiology 2011;80 (3):655-661 [PubMed]
  • Willemsen Anna E. C. A. B., van Herpen Carla M. L., Wesseling Pieter, Bult Peter, van Laarhoven Hanneke W. M. Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma Acta oncologica (Stockholm, Sweden) 2011;50 (3):462-465 [PubMed]
  • Desar I. M. E., ter Voert E. G. W., Hambrock Th, van Asten J. J. A., van Spronsen D. J., Mulders P. F. A., Heerschap A., van der Graaf W. T. A., van Laarhoven H. W. M., van Herpen C. M. L. Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study Cancer imaging 2011;11:259-265 [PubMed]
  • Visser Annemiek, Prins Judith B., Hoogerbrugge Nicoline, van Laarhoven Hanneke W. M. Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial BMC Women's health 2011;11:39 [PubMed]
  • Nagelkerke Anika, Mujcic Hilda, Bussink Johan, Wouters Bradly G., van Laarhoven Hanneke W. M., Sweep Fred C. G. J., Span Paul N. Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer Cancer 2011;117 (16):3670-3681 [PubMed]
  • ter Voert E. G. W., Heijmen L., van Laarhoven H. W. M., Heerschap A. In vivo magnetic resonance spectroscopy of liver tumors and metastases World journal of gastroenterology 2011;17 (47):5133-5149 [PubMed]
  • van Laarhoven Hanneke W. M., Schilderman Johannes, Verhagen Constans A. H. H. V. M., Vissers Kris C., Prins Judith Perspectives on death and an afterlife in relation to quality of life, depression, and hopelessness in cancer patients without evidence of disease and advanced cancer patients Journal of pain and symptom management 2011;41 (6):1048-1059 [PubMed]
  • Fleuren Emmy D. G., Versleijen-Jonkers Yvonne M. H., van de Luijtgaarden Addy C. M., Molkenboer-Kuenen Janneke D. M., Heskamp Sandra, Roeffen Melissa H. S., van Laarhoven Hanneke W. M., Houghton Peter J., Oyen Wim J. G., Boerman Otto C., van der Graaf Winette T. A. Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507 Clinical cancer research 2011;17 (24):7693-7703 [PubMed]
  • de Geus-Oei Lioe-Fee, Mavinkurve-Groothuis Annelies M. C., Bellersen Louise, Gotthardt Martin, Oyen Wim J. G., Kapusta Livia, van Laarhoven Hanneke W. M. Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity Journal of nuclear medicine 2011;52 (4):560-571 [PubMed]
  • van Schaik Ron H. N., Kok Marleen, Sweep Fred C. G. J., van Vliet Martin, van Fessem Marianne, Meijer-van Gelder Marion E., Seynaeve Caroline, Lindemans Jan, Wesseling Jelle, van 't Veer Laura J., Span Paul N., van Laarhoven Hanneke, Sleijfer Stefan, Foekens John A., Linn Sabine C., Berns Els M. J. J. The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients Pharmacogenomics 2011;12 (8):1137-1146 [PubMed]
  • van Laarhoven Hanneke W. M., Schilderman Johannes, Verhagen Constans A. H. H. V. M., Prins Judith B. Time perception of cancer patients without evidence of disease and advanced cancer patients in a palliative, end-of-life-care setting Cancer nursing 2011;34 (6):453-463 [PubMed]
  • Wennemers Marloes, Bussink Johan, Scheijen Blanca, Nagtegaal Iris D., van Laarhoven Hanneke W. M., Raleigh James A., Varia Mahesh A., Heuvel Joop J. T. M., Rouschop Kasper M., Sweep Fred C. G. J., Span Paul N. Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response Breast cancer research 2011;13 (4):R82 [PubMed]
  • Vriens Dennis, de Geus-Oei Lioe-Fee, Heerschap Arend, van Laarhoven Hanneke W. M., Oyen Wim J. G. Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET Clinical colorectal cancer 2011;10 (1):E1-E5 [PubMed]
  • van Laarhoven Hanneke W. M., Leget Carlo J. W., van der Graaf Winette T. A. When hope is all there is left oncologist 2011;16 (6):914-916 [PubMed]

2010

  • Desar Ingrid Advanced monitoring of targeted therapy in cancerNijmegen: 2010. ISBN 9789090257440. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Medische Wetenschappen. (Supervisors: van der Graaf Winette T. A., Oyen Wim J. G.; Co-supervisors: van Herpen Carla M. L., van Laarhoven Hanneke W. M.)
  • Gambarota Giulio, van Laarhoven H. W. M., Philippens M., Peeters W. J. M., Rijken P., van der Kogel A., Punt C. J. A., Heerschap A. Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma Applied magnetic resonance 2010;38 (3):349-360 [PubMed]
  • Vriens D., de Geus-Oei L. F., van Laarhoven H. W. M., van der Heijden H. F. M., Krabbe P. F. M., Visser E. P., Oyen W. J. G. Comparison of two region of interest definition methods for metabolic response evaluation with [¹⁸F]FDG-PET quarterly journal of nuclear medicine and molecular imaging 2010;54 (6):677-688 [PubMed]
  • Quak Elske, van Laarhoven Hanneke W. M., Bos Henk, Bouwhuis Jolande W., van Herpen Carla M. L., van der Graaf Winette T. A. Diarree en koorts bij chemotherapie door listeriose Nederlands tijdschrift voor geneeskunde 2010;154:A1645 [PubMed]
  • van Laarhoven Hanneke W. M., Schilderman Johannes, Vissers Kris C., Verhagen Constans A. H. H. V. M., Prins Judith Images of god in relation to coping strategies of palliative cancer patients Journal of pain and symptom management 2010;40 (4):495-501 [PubMed]
  • Heskamp Sandra, van Laarhoven Hanneke W. M., Molkenboer-Kuenen Janneke D. M., Franssen Gerben M., Versleijen-Jonkers Yvonne M. H., Oyen Wim J. G., van der Graaf Winette T. A., Boerman Otto C. ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model Journal of nuclear medicine 2010;51 (10):1565-1572 [PubMed]
  • Span Paul N., van Laarhoven Hanneke W., Sweep Fred C. G. J. Mammaglobin RT-qPCR for breast cancer metastasis detection in sentinel lymph nodes Cancer science 2010;101 (11):2501; author reply 2502 [PubMed]
  • van Laarhoven Hanneke W. M., Fiedler Walter, Desar Ingrid M. E., van Asten Jack J. A., Marréaud Sandrine, Lacombe Denis, Govaerts Anne-Sophie, Bogaerts Jan, Lasch Peter, Timmer-Bonte Johanna N. H., Lambiase Antonio, Bordignon Claudio, Punt Cornelis J. A., Heerschap Arend, van Herpen Carla M. L. Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041) Clinical cancer research 2010;16 (4):1315-1323 [PubMed]
  • Aarntzen E. H. J. G., van der Graaf W. T. A., van Laarhoven H. W. M. Scrotal and inguinal mass Netherlands journal of medicine 2010;68 (9):367-370 [PubMed]
  • van Laarhoven Hanneke W. M., Schilderman Johannes, Verhagen Constans A., Prins Judith Spiritual care in patients with advanced cancer: what does it imply? Journal of clinical oncology 2010;28 (20):e332; author reply e333 [PubMed]
  • Span P. N., van Laarhoven H. W., Sweep F. C. G. J. Tamoxifen sensitivity and estrogen receptor mRNA levels Breast cancer research and treatment 2010;121 (3):793-794 [PubMed]
  • Podo Franca, Buydens Lutgarde M. C., Degani Hadassa, Hilhorst Riet, Klipp Edda, Gribbestad Ingrid S., van Huffel Sabine, van Laarhoven Hanneke W. M., Luts Jan, Monleon Daniel, Postma Geert J., Schneiderhan-Marra Nicole, Santoro Filippo, Wouters Hans, Russnes Hege G., Sørlie Therese, Tagliabue Elda, Børresen-Dale Anne-Lise Triple-negative breast cancer: present challenges and new perspectives Molecular oncology 2010;4 (3):209-229 [PubMed]

2009

  • Desar I. M. E., van Herpen C. M. L., van Laarhoven H. W. M., Barentsz J. O., Oyen W. J. G., van der Graaf W. T. A. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy Cancer treatment reviews 2009;35 (4):309-321 [PubMed]
  • Vriens Dennis, van Laarhoven Hanneke W. M., van Asten Jack J. A., Krabbe Paul F. M., Visser Eric P., Heerschap Arend, Punt Cornelis J. A., de Geus-Oei Lioe-Fee, Oyen Wim J. G. Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate Journal of nuclear medicine 2009;50 (11):1777-1784 [PubMed]
  • van Laarhoven Hanneke W. M., Leget Carlo J. W., van der Graaf Winette T. A. Dying at the right time: a modern dilemma oncologist 2009;14 (6):642-643 [PubMed]
  • Vriens Dennis, de Geus-Oei Lioe-Fee, van Laarhoven Hanneke W., Timmer-Bonte Johanna N. H., Krabbe Paul F. M., Visser Eric P., Oyen Wim J. G. Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies Nuclear medicine communications 2009;30 (7):550-557 [PubMed]
  • Gilad Assaf A., van Laarhoven Hanneke W. M., McMahon Michael T., Walczak Piotr, Heerschap Arend, Neeman Michal, van Zijl Peter C. M., Bulte Jeff W. M. Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles Magnetic resonance in medicine 2009;61 (4):970-974 [PubMed]
  • Helmich Rick C. G., van Laarhoven Hanneke W. M., Schoonderwaldt Hennie C., Janssen Mirian C. H. Ischemic neuropathy and rhabdomyolysis as presenting symptoms of postpartum cardiomyopathy Journal of thrombosis and thrombolysis 2009;27 (4):458-460 [PubMed]
  • Long Christopher M., van Laarhoven Hanneke W. M., Bulte Jeff W. M., Levitsky Hyam I. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes Cancer research 2009;69 (7):3180-3187 [PubMed]
  • de Geus-Oei Lioe-Fee, Vriens Dennis, van Laarhoven Hanneke W. M., van der Graaf Winette T. A., Oyen Wim J. G. Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review Journal of nuclear medicine 2009;50 (Suppl. 1):43S-54S [PubMed]
  • van Laarhoven Hanneke W. M., Schilderman Johannes, Prins Judith Religious coping and life-prolonging care JAMA 2009;302 (3):257; author reply 257-257; author reply 258 [PubMed]
  • van Laarhoven Hanneke W. M., Vinken Maarten, Mus Roel, Flucke Uta, Oyen Wim J. G., van der Graaf Winette T. The diagnostic hurdle of an elderly male with bone pain: how 18F-FDG-PET led to diagnosis of a leiomyosarcoma of the adrenal gland Anticancer research 2009;29 (2):469-472 [PubMed]
  • Lesterhuis Willem Joost, Rennings Alexander J., Leenders William P., Nooteboom Arjan, Punt Cornelis J., Sweep Fred C., Pickkers Peter, Geurts-Moespot Anneke, van Laarhoven Hanneke W., van der Vlag Johan, Berden Jo H., Postma Cor T., van der Meer Jos W. Vascular endothelial growth factor in systemic capillary leak syndrome American journal of medicine 2009;122 (6):e5-e7 [PubMed]

2008

  • van Laarhoven H. W. M., Blokx W. A., Seyger M. M. B., Koopmans P. P. A patient with abdominal pain and a rash Netherlands journal of medicine 2008;66 (1):48-49 [PubMed]
  • de Geus-Oei L. F., van Laarhoven H. W. M., Visser E. P., Hermsen R., van Hoorn B. A., Kamm Y. J. L., Krabbe P. F. M., Corstens F. H. M., Punt C. J. A., Oyen W. J. G. Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer Annals of oncology 2008;19 (2):348-352 [PubMed]

2007

  • Gilad Assaf A., McMahon Michael T., Walczak Piotr, Winnard Paul T., Raman Venu, van Laarhoven Hanneke W. M., Skoglund Cynthia M., Bulte Jeff W. M., van Zijl Peter C. M. Artificial reporter gene providing MRI contrast based on proton exchange Nature biotechnology 2007;25 (2):217-219 [PubMed]
  • van Laarhoven H. W. M., Klomp D. W. J., Rijpkema M., Kamm Y. L. M., Wagener D. J. Th, Barentsz J. O., Punt C. J. A., Heerschap A. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil NMR in biomedicine 2007;20 (2):128-140 [PubMed]
  • Klomp Dennis, van Laarhoven Hanneke, Scheenen Tom, Kamm Yvonne, Heerschap Arend Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver NMR in biomedicine 2007;20 (5):485-492 [PubMed]

2006

  • van Laarhoven H. W. M., Veerkamp M. J., Pruszczynski M., van Deuren M. A patient with swollen ears and ECG abnormalities Netherlands journal of medicine 2006;64 (4):130, 132 [PubMed]
  • Gambarota Giulio, van Laarhoven Hanneke W. M., Philippens Marielle, Lok Jasper, van der Kogel Albert, Punt Cornelius J. A., Heerschap Arend Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI Magnetic resonance imaging 2006;24 (3):279-286 [PubMed]
  • van Laarhoven Hanneke W. M., Gambarota Giulio, Lok Jasper, Lammens Martin, Kamm Yvonne L. M., Wagener Theo, Punt Cornelis J. A., van der Kogel Albert J., Heerschap Arend Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure Neoplasia (New York, N.Y.) 2006;8 (6):477-487 [PubMed]
  • van Laarhoven H. W. M., Gambarota G., Heerschap A., Lok J., Verhagen I., Corti A., Toma S., Gallo Stampino C., van der Kogel A., Punt C. J. A. Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas Investigational new drugs 2006;24 (1):27-36 [PubMed]
  • van Laarhoven Hanneke W. M., Kaanders Johannes H. A. M., Lok Jasper, Peeters Wenny J. M., Rijken Paul F. J. W., Wiering Bastiaan, Ruers Theo J. M., Punt Cornelis J. A., Heerschap Arend, van der Kogel Albert J. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer International journal of radiation oncology, biology, physics 2006;64 (2):473-482 [PubMed]

2005

  • van Laarhoven Hanneke W. M., de Geus-Oei Lioe-Fee, Wiering Bastiaan, Lok Jasper, Rijpkema Mark, Kaanders Johannes H. A. M., Krabbe Paul F. M., Ruers Theo, Punt Cornelis J. A., van der Kogel Albert J., Oyen Wim J. G., Heerschap Arend Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET Radiology 2005;237 (1):181-188 [PubMed]
  • van Laarhoven H. W. M., Bussink J., Lok J., Verhagen I., Punt C. J. A., Heerschap A., Kaanders J. H. A. M., van der Kogel A. J. Modulation of hypoxia in murine liver metastases of colon carcinoma by nicotinamide and carbogen Radiation research 2005;164 (3):245-249 [PubMed]
  • van Laarhoven Hanneke W. M., Punt Cornelis J. A., Kamm Yvonne J. L., Heerschap Arend Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy Critical reviews in oncology/hematology 2005;56 (3):321-343 [PubMed]

2004

  • van Laarhoven Hanneke W. M., Bussink Johan, Lok Jasper, Punt Cornelis J. A., Heerschap Arend, van der Kogel Albert J. Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters International journal of radiation oncology, biology, physics 2004;60 (1):310-321 [PubMed]
  • Gambarota G., Veltien A., van Laarhoven H., Philippens M., Jonker A., Mook O. R., Frederiks W. M., Heerschap A. Measurements of T1 and T2 relaxation times of colon cancer metastases in rat liver at 7 T Magma (New York, N.Y.) 2004;17 (3-6):281-287 [PubMed]
  • van Laarhoven Hanneke W. M., Willemsen Jacques J., Ross H. Alec, Beex Louk V. A. M., Lenders Jacques W. M., Sweep Fred C. G. J. Pitfall in HPLC assay for urinary metanephrines: an unusual type of interference caused by methenamine intake Clinical chemistry 2004;50 (6):1097-1099 [PubMed]
  • van Laarhoven Hanneke W. M., Punt Cornelis J. A. Systemic treatment of advanced colorectal carcinoma European journal of gastroenterology & hepatology 2004;16 (3):283-289 [PubMed]

2003

  • van Laarhoven Hanneke W. M., Verstappen Carla C. P., Beex Louk V. A. M., Kappelle Arnoud C., Punt Cornelis J. A. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug Anticancer research 2003;23 (1B):647-648 [PubMed]
  • van Laarhoven Hanneke W. M., Klomp Dennis W. J., Kamm Yvonne J. L., Punt Cornelis J. A., Heerschap Arend In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength Cancer research 2003;63 (22):7609-7612 [PubMed]
  • van Laarhoven Hanneke W. M., Rijpkema Mark, Punt Cornelis J. A., Ruers Theo J., Hendriks Jan C. M., Barentsz Jelle O., Heerschap Arend Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases Journal of magnetic resonance imaging 2003;18 (3):315-320 [PubMed]
  • Klomp Dennis W. J., van Laarhoven Hanneke W. M., Kentgens Arno P. M., Heerschap Arend Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver Magnetic resonance in medicine 2003;50 (2):303-308 [PubMed]

2002

  • Koolen D. A., van Laarhoven H. W. M., Wobbes Th, Punt C. J. A. Single-centre experience with tunnelled central venous catheters in 150 cancer patients Netherlands journal of medicine 2002;60 (10):397-401 [PubMed]

2001

  • van Laarhoven H. W., Rooyer F. A., van Engelen B. G., van Dalen R., Berden J. H. Guillain-Barré syndrome as presenting feature in a patient with lupus nephritis, with complete resolution after cyclophosphamide treatment Nephrology, dialysis, transplantation 2001;16 (4):840-842 [PubMed]